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Pain in the older person is often under reported and poorly assessed.  Access to better healthcare 
and improved social support has increased the average life expectancy resulting in older people 
having a higher prevalence of pain and related problems.  The British Pain Society supports and 
welcomes the 2ndedition of the publication of the “National Guidance on Managing Pain in the Older 
Adult”and would go alongside the 2018 publication National Guidance for the Assessment of Pain in 
Older People (Schofield et al 2018).  The International Association for the Study of Pain has marked 
2019 as part of the Global year against pain in the most vulnerable and the British Pain Society 
congratulate the efforts of Prof Schofield and colleagues in bringing out a valuable guide to 
healthcare care professionals in the practical aspects of delivering appropriate care and managing 
pain in these population.   
  
In the older adult, musculoskeletal pains due to osteoarthritis of the knee, hips, shoulder and small 
joints of the hand are common painful problems as well as neuropathic pain problems and cancer-
related pain.  The older generation has a stoic approach to pain and this along with traditional 
beliefs and attitudes makes pain management difficult as patients sometimes prefer a self-
management strategies, which on its own may only provide sub-optimal pain relief.  Often the 
unsaid words are more important in assessing the pain and valuable information is obtained from 
carers and healthcare practitioners in assessing the pain and related problems.  In nursing homes, 
this has led to increased use of opioids, which in turn gives rise to cognitive dysfunction and other 
undesirable side-effects which limits the increasing use of medicines to manage pain.  This highlights 
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the importance of multidisciplinary assessment and management of these patients in a timely 
manner.  This document jointly produced by the British Pain Society and the British Geriatric Society 
gives a comprehensive synopsis of the latest evidence in the prevalence, issues and management of 
pain in the older person.  
 
 
Dr Arun Bhaskar MBBSMSc FRCA FFPMRCA FFICM FIPP EDPM 
Clinical Lead & Consultant in Pain Medicine 
President, The British Pain Society 
 
The Royal College of Nursing welcomes the publication of the second edition of this guidance which 
builds upon the national guidance for the assessment of pain in older people (Schofield et al 2018). 
The launch is timely as it coincides with the significant work of the International Association for the 
Study of Pain global year 2019 campaign against pain in the most vulnerable jointly led by Prof Pat 
Schofield and Prof Miriam Kuntz.  
Pain in older people has a high prevalence, yet is under reported and is associated with frailty and 
falls. The older person’s attitudes and beliefs about their pain can be a barrier to effective 
management. Pain assessment and management in is often undertaken by informal carers and 
members of the nursing team and they are well placed to ensure that the effectiveness of 
interventions is assessed and recorded. Structured pain assessment remains a fundament of practice 
as the recognition of a neuropathic component will significantly change the treatment strategy. 
Musculoskeletal pain is very common in this population and remains highest in residential care 
settings.  
The increasing use of pain management programmes and exercise is to be lauded as pain is a 
biopsychosocial experience, maintaining strength and flexibility is important and as we age we have 
increased adverse effects from medicines.  
Felicia Cox FRCN MSc RN  
Chair RCN Pain and Palliative Care Forum 
 
Executive Summary 
The aim and objectives of this review were as follows: 
Aim: to provide up to date guidance on pain management for the older population (65+). 
Objectives 
1) To describe the population and current prevalence. 
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2) To identify the current literature regarding attitudes and beliefs held by health professionals 
and informal carers. 
3) To identify and present the latest evidence regarding pharmacological and non-
pharmacological management of chronic pain. 
4) To identify a global picture by reviewing national guidelines from around the world. 
5) To demonstrate the most current evidence regarding palliative pain for this population. 
6) A detailed review of the current evidence base for the management of pain in this 
population which should be viewed alongside the national pain assessment guidelines 
(2018) and as an addition to the national management guidelines published in 2013. 
 
This guidance document reviews the epidemiology and management of pain in older people via a 
systematic literature review of published research. The aim of this document is to inform any health 
professionals in any care settings who work with older adults on best practice for the management 
of pain and to identify any gaps in the evidence which may require further research. The assessment 




Within this publication we have included sections on palliative care and information for informal 
carers sections which is new. In terms of prevalence, the evidence remains the same in that pain 
increases with advancing age and is more common in females than makes. Knees, hips and back 
remain the common pain sites and pain associated with osteoporosis and osteoarthritis is common. 
As before we have focussed our review on chronic pain and community settings, but we still observe 
that pain prevalence is higher within the nursing home environment. This demonstrates that there 
has been very little change in pain management within this setting since 2013. 
Research into attitudes and beliefs has increased over the past five years with the recognition that 
certain beliefs result in an escalation of the pain experience amongst this population.  Furthermore, 
spousal beliefs have a significant impact upon how the individual copes with their pain. However, 
there is some research which demonstrates success in changing attitudes and beliefs by using CBT 
and pain management programmes an area worth expanding upon.  In terms of guidelines, we only 
reviewed those published in the English language, therefore, the three main countries of publication 
were UK, US and Australia. Other guidelines for example Germany were not written in English were 
therefore not reviewed, but we do acknowledge they exist. The evidence around carers perspectives 
emphasises that generally informal carers are based placed to lead on assessment and management 
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of pain decisions, even better than the named nurse, particularly when decisions are being made 
around palliative care. There is very little evidence regarding palliative care neds of those specifically 
over the age of 65years and nothing related to the promotion of a “good death” or related to other 
conditions such as COPD, heart failure or dementia. Nevertheless, what literature there is, in relation 
to the latter suggests that pain is a significant predictor of behaviour in adults with severe dementia. 
 
From a pharmacological perspective, there has not been much in the way of developments since the 
publication of the 2013 guidelines. It is still important to remember that older adults are more likely 
to be experiencing physiological changes which will make them susceptible to increased risk of side 
effects. Oral administration is the preferred route, although for some pain syndromes, topical can be 
more effective. Timing of drugs is of importance and only one drug should be added or changed at 
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Paracetamol is often recommended as the drug of choice, but we now know that there is an 
increased likelihood of adverse events associated with long term use. None of the NSAIDs are safe in 
this population, so they should only be used for the shortest time, including topical. Opioids should 
only be used for the shortest duration. Buprenorphine is more cost effective than Fentanyl and most 
commonly studied in the UK. Morphine is the most effective in end of life care. Gabapentin, 
pregabalin, amitriptyline and duloxetine are considered the most appropriate first line treatment for 
the management of neuropathic pain. 
 
As in the 2013 guidelines, the evidence base for the current guidelines is limited. In spite of the fact 
that there is a strong rationale for the use of psychological approaches. It would appear that there is 
still limited evidence for CBT as an effective treatment for chronic pain in older people however; the 
numbers of papers which consider pain management programmes and more novel interventions 
suggest that combined or integrated strategies to manage chronic pain may be beneficial to older 
populations. 
 
In terms of physical activity. It is well documented that exercise is beneficial for the management of 
chronic pain. But as with the 2013 guidelines there has still been limited research in terms of 
exercise specific to older adults. From the evidence we did review, we are able to conclude that 
exercise should be tailored to the needs of the individual regardless of age and should involve 
strengthening, endurance and flexibility exercises as an important role in self-management. But 
understanding motivation and barriers to exercise is an important factor and should be supported 
with education to aid understanding of the rationale behind the exercise. 
 
In terms of invasive approaches, we focussed upon specific conditions. Trigeminal neuralgia, 
Vertebroplasty & Kyphoplasty revealed no new studies. It is important therefore to refer to the 2013 
guidelines. In terms of spinal stenosis, caudal epidural with local anaesthetic with or without steroids 
effect pain relief. Epidural or percutaneous epidural adhelyosis can treat specific types of stenosis 
depending on the location of the stenosis. Spinal cord stimulation gives pain relief for a considerable 
time if not a curative approach. In terms of PHN, there is one study using fTMS. The findings suggest 
that repeated daily stimulation deliver prolonged pain relief lasting 1-3 months than a single rTMS 
session with effects lasting less than a week. The treatment of postherpetic neuralgia pain in older 
people is limited to findings of this one study. However, it is clear that repetitive transcranial 
magnetic stimulation (rTMS) can be of value in selected patients with postherpetic neuralgia in 
relieving pain for up to 3months. 
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The recommendations in this paper are informed by a comprehensive literature review utilising a 
systematic approach.  
Methodology  
This paper builds on the previous work (2). A team of pain professionals including members of the 
British Geriatric Society, British Pain Society and Royal College of Nursing worked together to 
produce a comprehensive overview of the guidance for pain management in older people. The team 
comprised of representatives from care of older people and pain specialists. The professions 
represented included epidemiology, geriatric medicine, pain medicine, nursing, physiotherapy, 
occupational therapy, psychology, pharmacology and service users. Members of the team were 
allocated to representative groups related to particular aspects of the topic of pain in older people.  
At a preliminary meeting groups were established to revisit the areas identified in the earlier 
guidance with the addition of two further areas for consideration namely palliative care and carers. 
After general discussion about approaches to start the search a few key terms were identified for an 
initial generic search to be undertaken. An information scientist supported the generation of an 
initial search (main strategy noted in Appendix 1), from this a database was generated utilising the 
bibliographic software RefWorks to enable the sharing of references. Separate search strategies 
were then used to identify particular papers supporting the identified subtopics of physical therapy, 
prevalence, attitudes, carers, palliative care, education, pharmacology, interventions, psychology 
and assistive devices. 
Each group member identified topic specific key terms to enable searching.  
Papers were rejected that did not meet the following inclusion criteria:  
• Studies in English language.  
• Types of study: randomised controlled trials (RCTs), cohort studies, non-experimental studies and 
descriptive studies.  
• Types of participants: all adults over 65 years with chronic pain, living in community settings 
• Interventions and specific comparisons to be made: all drug and non-drug intervention studies, 
including comparisons with placebo, standard care and waiting list control. 
The recommendations provided here are based on an initial literature search using Medline, CINAHL, 
the Cochrane Central Register of Systematic Reviews and Psychinfo. A systematic search strategy 
was undertaken using both Boolean search and proximity operators in May 2018 including papers 
published between 2009 (the date of the last review) and April 2018.  Reference lists of papers and 
review articles were also searched for possible inclusions. The process of development of this paper 
followed the reporting guidelines identified by Moher et al (3).  
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Quality of included papers was assessed using the Sottish Intercollegiate Guidelines Network (SIGN) 
methodological grading system.  
(https://www.sign.ac.uk/assets/sign_grading_system_1999_2012.pdf). 
Following acceptance of papers, each author graded the papers according to the following system, 
as proposed by Harbour & Miller (4) 
1 ++ High quality meta -analysis, systematic reviews of RCTs or RCTs with a very low risk of bias. 
1 + Well-conducted meta-analyses, systematic reviews of RCTs or RCTs with a low risk of bias. 
1 – Meta-analysis, systematic reviews or RCTs or RCTs with a high risk of bias. 
2 ++ Hi quality systematic reviews of case control or cohort studies or high quality case -control or 
cohort studies with a very low risk of confounding bias or chance, and a high probability that the 
relationship is causal. 
2+ Well conducted case-control or cohort studies with a low risk of confounding bias or chance and a 
moderate probability that the relationship is causal. 
2 – Case-control or cohort studies with a high risk of confounding, bias or chance and a significant 
risk that the relationship is not causal. 
3 Non-analytic studies, e.g. case reports, case series. 
4 Expert opinion.  
Results  
A main initial search identified a total of 6751 papers from Medline and CINAHL and from Psychinfo 
a further 1173 records within which the reviewers searched for the particular topics as detailed in 
each of the following sections. 
Background 
Pain in older people is a potentially huge problem. The pain experienced by older people is largely 
under reported and consequently poorly managed. It has been well documented that 40% of older 
adults living in the community are experiencing poorly controlled chronic pain and this figure 
increases significantly in the nursing home population to as high as 80% (1). We are also aware that 
the population is ageing. In the UK as with the rest of the world we are going to see a significant 
increase in the older population over 65 years and those over 85 years. Chronic pain in this 
population is associated with increased risk of falls and an increase in frailty. Therefore, it is essential 
that we have national guidance for both the assessment and the management of pain in the older 
population. The assessment guidance was republished in 2018. This is an update on the 2013 Paper 
"Guidance on the Management of Pain in Older People" (2). It is anticipated that these guidelines 
will be updated in 3-5 years.   
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At the time of writing we are aware that there is constantly changing literature in the field of pain 
and a growing body of evidence in the care of older adults. We feel that this is a snapshot in time 
and should be viewed alongside the 2013 guidelines as there have been some changes. 
Prevalence of Pain in Older Adults. 
Eighty-five papers relating to prevalence were initially identified from within the main search out of 
which 49 were finally selected for inclusion. The majority (n = 10) were from the USA, with Korea (n 
= 4), Sweden (n=4) and Canada (n = 3) being the next highest. There was only one paper from the 
UK. From the studies we found that there were three conducted in nursing homes, and a fourth 
study conducted in a veterans' hospital in the USA. There was one hospital study and the rest were 
community based. 
From a methodological perspective, the majority of the studies were surveys (n= 21), although some 
of these studies appeared to be more epidemiologically focused using large data bases. Other 
studies were described as longitudinal, cross sectional, observational, case note review, cohort 
studies and one interview study. There were four systematic reviews. The sample sizes were quite 
large in many of the surveys. For example, the study from New South Wales utilised 8881 
participants (5) and a USA based internet study utilised 35718 participants (6). 
The results of the studies are very similar to those found in the studies of the 2014 guidelines (2). All 
of the studies with the exception of one found that pain prevalence increased with advancing age. 
The study by Fejer & Ruhe (7) contradicted this result with their systematic review by demonstrating 
a reduction in pain complaints over the age of 80. All of the studies supported the concept that 
females are more prone to expression of pain than males. The most common pain complaints as 
reported previously were knees, hips and low back pain. Only one paper reported that females 
reported more pain sites including; hands, shoulders, neck, back, hips, knees and feet in a USA 
cohort study of 5093 male participants (8). There was also a consensus that the pain was associated 
with osteoporosis or osteoarthritis (9). 
 
 A few new findings post 2014 were identified with this review. For example, in a study of 4703 
participants over 75 years in the last two years of their lives demonstrated that 24% of the patients 
had chronic pain and in 60% of this cohort the pain was associated with arthritis. The prevalence of 
pain increased in the last four months of life (10). A predisposing factor for chronic pain in later life is 
obesity (11, 12). A number of papers discussed self-management of pain in this age cohort (13,14). 
But the authors commented that use of self-management was largely due to undertreatment by 
pharmacological methods.  
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In contrast, a study by Hemmingsson et al (15), which looked at pain prevalence in nursing home 
residents, found an increase in the use of opioid prescribing, but a decrease in the use of Tramadol. 
 
A high incidence of neuropathic pain was found in a nursing home population across 12 nursing 
homes in Holland using a case note survey (16). In terms of dementia, a cross sectional survey in the 
USA demonstrated that 63% of older adults with dementia had chronic pain compared to 54% of 
adults without dementia in a sample of 7609 community dwelling older adults (17).  
Summary:  
In conclusion, ageing and disability increases the potential for chronic pain (18). The common pain 
sites are knees, hips and low back often associated with osteoarthritis and osteoporosis. Females are 
more likely to develop chronic pain and it is often associated with obesity. Older adults with 
dementia are more likely to be experiencing chronic pain. Whilst there are a number of studies 
reporting the prevalence of chronic pain in this population acknowledging the phenomenon exists, 
undertreatment remains rife. 
Attitudes and Beliefs: 
This section explores the role of attitudes and beliefs in relation to how older adults experience and 
cope with chronic pain, and the resulting functional and psychological consequences. While within 
this population underlying physiological processes relating to ageing do have an impact upon chronic 
pain, it is also affected by psychological, cognitive and societal factors which the biopsychosocial 
model of pain recognises. Within this model research has explored and demonstrated that attitudes 
and beliefs of older adult patients can have a significant influence on how they cope with their pain, 
their help-seeking behaviours, how they engage with treatment and therapy, and the level of 
impairment it causes physically and psychologically (19). The following review explores literature in 
this area, contributing to the rationale that older adults’ beliefs and attitudes are implicated in how 
pain should be recognised and treated, and thus need to be considered by healthcare providers 
supporting this population.  
Review: 
Research indicates attitudes and beliefs can be implicated in older adults’ willingness to seek help or 
treatment for their pain. Makris et al. (20) found older adults anticipated and therefore accepted 
pain as a part of the ageing process. This belief, which was reinforced by ageist and dismissive 
attitudes from healthcare providers, lead to a reluctance to seek help, as healthcare providers were 
perceived as unable to assist. Stoicism, or the belief pain should be accepted or hidden from others, 
was a consistent theme within other studies found. Cornally & McCarthy (21) found 78% of older 
adults in their sample indicated ‘it is no good complaining about their pain’.  
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Older adults who hide pain or express stoicism expectedly, are less willing to seek help (21). It may 
also be older adults are less willing to seek help due to how they prioritise their chronic pain. Older 
adults from 65 years to over 80 years believe pain is not a priority in the presence of often multiple 
competing comorbidities (20, 22). 
Pain beliefs not only affect older adults’ willingness to seek help, but also their psychological 
wellbeing and functional ability. Older adults who stoically accept pain as a part of ageing report loss 
of independence and control, depressive symptoms, loneliness and disability in daily activities (20, 
23, 24, 25, 26). This suggests this belief leads to a psychological and physiological hopelessness 
among older adults, which may explain the lack of coping skills or mechanisms for pain discussed in 
the literature. Interestingly, Tse & Vong (23) found older adults who express hopelessness in that 
their pain will be constant and permanent, also report more intense pain. Alternatively, more 
intensive pain may contribute to more psychological disturbance. 
Fear avoidance beliefs have also been found to effect older adults’ willingness to engage in pain 
treatment (27, 28). According to the fear-avoidance model, fear avoidance beliefs and resulting 
behaviours can lead to individuals becoming trapped in a cycle of chronic disability and pain (29). 
Indeed evidence indicates this is applicable among older adults; fear avoidance beliefs such as 
activity will cause symptom escalation and pain is sign of damage, are associated to poorer physical 
performance, avoidance of activity, lower gait speed and increased disability (24, 27, 28). One study 
reported fear avoidance beliefs relating to exercise was greater in those with more severe pain 
which required surgery, suggesting the greater the pain and necessary intervention the greater the 
associated fears (28). Fears and beliefs about treatment options, such as medications and surgical 
interventions not only affect engagement with treatment but also willingness to receive future 
treatment (20).  
Recognising the impact of attitudes and beliefs in the treatment of chronic pain, a number of studies 
have developed educational or training programmes to improve attitudes and beliefs in relation to 
pain and exercise.  
Green et al. (30) and Nicholas et al. (26) both developed programmes using principles of cognitive 
behavioural therapy (CBT) which were successful as reducing fear-avoidance of exercise and 
maladaptive organic pain beliefs. The programmes also reduced distress and depressive symptoms 
and encouraged physical activity for the self-management of pain. Both programmes demonstrated 
long-term effects, for as long as 1-year post-programme (26). Other programmes not of a CBT 
orientation have demonstrated similar successes, promoting more positive views towards exercise 
and a better understanding of conditions, however they also highlighted limitations (31,32).  
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Hurley et al. (31) found older adults maintained maladaptive beliefs that pain is inevitable with age, 
untreatable and exacerbated by activity. This led to acceptance of disability, avoidance of help 
seeking and poorer adherence or engagement with treatment plans. Once again demonstrating, not 
only the significant impact of beliefs and attitudes but additionally, the challenges faced in 
attempting to change them.  
The evidence reviewed indicates that healthcare practitioners must consider older adults’ attitudes 
and beliefs, and how they may be implicated in their willingness to help-seek, and their responses to 
treatments, particularly that which requires physical activity. They must also consider screening and 
evaluation of older adults’ psychological state, the research reviewed suggests an intertwined 
relationship between pain beliefs, and psychological and physical disability. Research developing 
interventions to alter older adults’ attitudes and beliefs indicates CBT may offer a means to deliver 
successful and sustainable gains, however more research is needed to explore how such 
programmes can be delivered within the reality of healthcare contexts.  
This guideline and its recommendations echoes those made previously; however there has been a 
significant increase in papers identified which suggests a growing recognition of the importance of 
the patient experience and perspective. This has allowed for a more in-depth discussion on the 
relationship of older adults’ attitudes and beliefs on treatment engagement and outcomes. Akin to 
the previous guidelines, stoicism and fear-avoidance continue to be key obstacles, however 
interestingly no generational differences in either were explicitly explored in the studies despite 
samples ranging from 65 years to over 80 years. Likewise, all but one study (21), compared 
differences in attitudes and beliefs based on individual differences. In terms of the sample 
populations, all but one (23) were based in the community, while there is an increasing move for 
ageing in place older adults within residential care have consistently higher pain prevalence than 
those living in the community (2). This suggests literature found does not include a significant 
proportion of older adults with chronic pain. Most study samples were recruited through visits to 
healthcare services or data was derived as secondary analysis. Samples were therefore 
unrepresentative of those older adults who do not self-present or do not have access to healthcare.  
The previous guideline discussed the role of spousal beliefs and attitudes, and how these can impact 
upon a significant other’s pain experience, no papers were found further exploring this issue. 
Considering the landscape of care currently and the significant role of familial/spousal caregivers in 
supporting older adults, it is perhaps surprising their attitudes and beliefs about pain were 
unrepresented in the current literature.  
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Finally, the attitudes and beliefs of healthcare providers was beyond the scope of this review, 
however the literature reviewed does indicate they have ageist and stigmatising views of pain, and 
that these can reinforce older adults maladaptive beliefs and avoidance of help-seeking. This 
highlights the importance of looking at both patients and healthcare providers’ attitudes and beliefs 
together.  
Summary:  
• Older adults accept their chronic pain with stoicism and demonstrate fear avoidance beliefs, 
which prevents them from help-seeking, and leads to treatment avoidance and poor engagement 
with treatment recommendations.  
• There is an intertwined relationship between pain beliefs and functional and psychological 
impairments caused by chronic pain. Certain pain beliefs exacerbate disability and cause escalation 
of chronicity.  
• Educational and training programmes implementing principles of CBT demonstrate some 
sustainable gains in reducing maladaptive attitudes and beliefs. However, more work is needed to 
see how such programmes can be successfully integrated into healthcare care.  
• Since the previous guidelines, research in the area has increased, such reveals a growing 
recognition of the significance of the older adults’ perspective in the assessment of pain and 
planning of pain management within this population. This is not to say however, there remains 
limitations of this current body of literature.  
• The evidence presented provides a clear recommendation, that healthcare providers must 
consider older adults attitudes and beliefs, in addition to their psychological state, when addressing 
pain in this population.  
Guidelines  
This section offers a brief overview of other existing guidelines published in the area since the 
development of the previous guideline document (2), including those from the UK and around the 
world. Guidelines from some countries, such as the German Pain Society and the Spanish Society of 
Pain, are not discussed as have not been published in English. 
Only a handful of English language guidelines for pain management in older adults specifically have 
been identified (33, 34, 35, 36) since Abdulla et al. (2).  
As mentioned in the previous document, in 2009 the American Geriatric Society (35) updated their 
guidelines for the management of persistent pain in older adults and subsequent supplementary 
documents were published in 2011 (33). This update and supplementary documents discuss drug 
and non-pharmacological management, additional methods for assessing pain in the cognitively 
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impaired and age-related physiological changes which should be considered. The risk of NSAIDs for 
older adults is a key theme.  
More recently in 2018, the Australian Pain Society updated their 2005 guidelines on the 
management of pain for older adults’ livings in residential settings (36). This update includes sections 
on end-of-life pain management and nutrition and it directed at all healthcare staff involved in the 
assessment and management of pain in older populations.  
A number of other guidelines which are not age discriminative or developed for older people are 
available for clinicians and healthcare providers’ reference. The Scottish Intercollegiate Guidelines 
Network have developed general guidelines on the management of chronic pain (37) and The 
Canadian guidelines for opioid therapy (38) offer recommendations on the management of 
persistent non-cancer pain. Similarly, the British Medical Association (39) has produced guidelines 
supporting the safe prescription of analgesics. Other condition specific guidelines have also been 
developed such as the NICE guidelines on the management of neuropathic pain (40).  
For pain management at end-of-life NICE (41) and the British Medical Association (39) have both 
provided documents covering palliative pain management, including routes of administration and 
management of opioid side-effects. Other guidelines which have been developed are orientated 
towards the provision of pain management programmes and services (42, 2). These documents offer 
clinical guidance for those delivering pain management programmes and offer a framework for 
organisations or commissioners involved in the planning or sustainability of these programmes.  
The guidelines discussed identify some concerning gaps in the evidence base which underpin the 
recommendations made. Similar to this document, the American Geriatrics Society (35), the UK 
National Institute for Health & Care Excellence (43), the British Medical Association (39) and Scottish 
Intercollegiate Guidelines Network (37) comment on the deficiency of high-quality evidence for the 
efficacy and safety of pharmacological and non-pharmacological pain management. This has resulted 
in recommendations which are based on expert consensus rather than evidence-based, or indeed 
not based on age-appropriate evidence. The latter might explain the lack of older adult specific 
guidelines available too, given the paucity of research to inform best-practice recommendations.  
Summary:  
• Guidelines for the management of pain in older adults written in English have been 
developed in the UK (2); the US (35); and Australia (36).  
• Other guidelines which are not age discriminative are available to offer recommendations 
for the management of specific conditions (e.g. neuropathic pain, NICE 40), end-of-life pain 
management (39, 41), and non-cancer chronic pain (37, 38, 43). 
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• The evidence-base to inform guidelines is still limited, resulting in recommendations 
informed by expert opinion, not high-quality evidence. 
 
Older adults living with chronic pain: the impact upon carers  
Carers, often a family member, provide care, typically unpaid, to someone with whom they have a 
personal relationship and who would have difficulty coping without this support. Increasingly, carers 
are being relied upon to provide care and support to enable older relatives to live at home and age 
in place. With advancing years, the prevalence of pain and disease can increase and carers may take 
on greater responsibilities. Carers may act as proxy decision makers, they can be involved in 
symptom assessment and treatment management and may have their own health and information 
needs alongside those of the cared for person. These needs may continually change, which can be a 
source of anxiety and contribute to the overall burden experienced by carers.   
Chronic pain in the context of palliative care and dementia/cognitive impairment featured in eight of 
the ten papers. In keeping with one of the central tenets of palliative care, which offers a support 
system to help family members cope during the patient’s illness and in their own bereavement, 
those papers that focused on palliative pain management evidenced the impact of chronic pain and 
the role of informal carers with the greatest clarity.      
Palliative pain 
The roles and perspectives of carers in managing pain in the context of palliative care was the focus 
of three articles (44, 45, 46). Findings from both McPherson papers (44, 45) were derived from the 
same dataset to describe the lived experience of cancer pain from the perspectives of both older 
patients living at home and their caregivers.  An emphasis on dyads rather than the separate 
experiences of patients and caregivers gave credence to the interactional process of caregiving. The 
only UK based study included in this section was an article by Dawber et al (46). The authors 
examined the agreement between patients, their named nurse and family carers in terms of pain 
symptom assessment on the medical wards of a district general hospital. They found family carers 
were better proxies for patients when assessing pain when compared to the named nurse. Given the 
subjectivity of pain, family carers’ personal knowledge of the patient was deemed important in 
determining pain symptoms. 
Pain management in patients with dementia/cognitive impairment 
Poor pain management (untreated pain) for older adults with cognitive impairment who are unable 
to communicate verbally, has been identified as a risk factor for depression and agitation of carers; 
the roles and perspectives of carers featured in five articles in this section.  A study by Murray et al 
(47) in an urban outpatient clinic in Chicago, with a convenience sample of people with dementia 
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(PWD) and their carers, compared the most bothersome symptoms as reported each by PWD and 
their carers, to establish whether common symptom assessment measures captured what was most 
important to each group. Pain was the most frequently reported symptom by PWD; for carers, pain 
was the second most frequently reported after symptoms of cognitive decline. This highlighted the 
priority given to routine pain assessment by both PWD and their carers. Another US-based study also 
examined carer report of patient pain (48). Involving a community-based sample of 272 older adults 
and their carers, the authors evaluated which specific behavioural and psychiatric symptoms of 
dementia (BPSD) were associated with carer reports of patient pain. Their findings indicated that 
pain was a more significant predictor of behaviour for individuals with severe dementia compared to 
those with mild/moderate dementia. The role of caregivers was a central tenet of the article by 
Kaiser and Kaiser (49) which illustrated their personal account of caring for their 90-year old mother 
with Alzheimer’s disease. They highlighted their experiences of poor pain management for their 
mother and advocated the development of improved training for health professionals in order to 
engage and collaborate with family carers from hospital to home to ensure a seamless plan of care.   
Two articles that provided a description of the Preventing Aggression in Veterans with Dementia 
(PAVeD) intervention, explored whether identifying pain and emotional distress as risk factors and 
incorporating the carer into the treatment process, would help prevent or alleviate aggressive 
behaviour in people with dementia, thereby helping to reduce carer burden (50, 51).  It was a family-
centred intervention that could be tailored to individual situations. However, a randomised 
controlled trial of the intervention did not demonstrate any differences in the incidence of 
aggression or pain levels between those who had received the skills training compared to those who 
had not and whilst this is an important negative finding, quantitative evaluations can provide an 
incomplete assessment of carers’ experiences. 
General pain studies 
The two remaining articles explored carers’ perspectives of their older relatives’ pain and the impact 
of pain on family relationships. Hsu et al (52) explored carers’ observations and perceptions of their 
older relatives’ knee osteoarthritis pain and pain management. This was a convenience sample of 28 
family members from one medical centre and a regional hospital in Taiwan. In this descriptive study, 
the older adults described their pain to their relatives and its impact on their activities and 
functioning.  
However, they were reluctant to take regular pain medicine and waited until they could no longer 
tolerate the pain before taking analgesia. This was due to negative attitudes regarding pain 
medication such as worries about side-effects or possible addiction. The carers in this study reported 
observing their relatives’ pain in terms of limitations to their activities and described their roles as 
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needing to find a solution by taking the care-recipient to see a doctor or encouraging surgery. 
Pillemer et al (53) considered the impact of older parents’ pain symptoms on the quality of the 
parent-adult child relationship. This study was conducted in the US with 698 adult children within 
293 families. Whilst the expectation was that the presence and severity of pain would negatively 
affect the relationship between mother and adult child, this was not found to be the case. 
 
Summary statements  
• Carers take on roles in pain management in terms of communication, being an advocate, 
assessing pain, managing side-effects and finding solutions. 
• Once patients are unable to self-report pain, carers can act as proxies in pain assessment 
which may be more accurate than health care professional assessment due to their personal 
knowledge of the cared for person. However, assessing pain can be challenging for carers due to the 
complexities associated with the presence of co-existing symptoms and the impact of a high carer 
burden associated with the demands of the caring role. 
• Involvement in helping others with their pain management can be a source of worry, 
concern, upset, frustration, and anger for carers. 
• Educational and family-centred interventions have had limited benefits in supporting carers 
in their pain management roles. However, a more integrated approach involving a co-existing and 
evolving care between formal and informal health systems has been suggested.  
• The relationships between health care professionals and caregivers are important as a 
means to improving pain management for older adults.   
Palliative and end-of-life care  
As the population demographic changes so early diagnosis and management of previously life 
limiting conditions, including cancers and co-morbidities of ageing, has led to increased longevity 
(54). However, this leaves many with long term chronic conditions and unmet palliative healthcare 
concerns including pain. 
Only five articles related to the provision of palliative and end-of-life care pain management for 
adults aged 65 years and over to meet the criteria for inclusion (54, 55, 56, 57, 58).  The same author 
had published two of these papers using the same dataset.   
The articles reviewed focused on cancer, mixed acute and chronic end-of-life care pain management 
in various settings that included hospital, hospice and the community.  Studies were mainly 
retrospective, longitudinal cohort, cross-sectional and non-randomised design studies. 
With claims of limited evidence to address whether differences exist in the management of cancer 
pain between patients receiving usual care by hospital-based primary specialists and those receiving 
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an early palliative/supportive intervention, Bandieri et al (54) addressed this and found that in the 
choice of analgesic strategy, the main recommendations provided by international guidelines were 
better adhered to with the adoption of an integrated care model compared to a routine approach.   
 
Findings from their study identified that the risk of severe pain was reduced when an integrated care 
model was used compared with a model of routine care based on the involvement of a primary 
specialist alone.  Likewise, research conducted by Laguna et al (57) has demonstrated inpatient 
palliative care (IPC) teams’ effectiveness in managing pain during hospitalization but suggest a lack 
of continuity in pain management following discharge.  These findings support IPC effectiveness in 
managing patient pain during hospitalization and reinforce the need for improved care coordination 
and support during care transitions.  Using the same dataset, Laguna et al (58) investigated pain 
differences between whites, blacks, and Latinos after an IPC intervention and found a significant 
reduction in self-reported pain across all racial and ethnic groups.  Despite these reductions, Latinos 
remained 62% more likely than whites to report experiencing pain at hospital discharge.  Although 
limited in its inability to explain these findings, IPC teams with greater awareness and recognition of 
the potential influence of religious and cultural beliefs held by particular racial and ethnic groups 
deemed a potential barrier to palliative care pain management enables strategies to be put in place.   
 
 A study conducted by Fisher et al (55) focused on patients diagnosed with colorectal cancer (CRC) 
living exclusively in the community advocating the role of palliative care programmes (PCPs) as a 
means to enabling access to end-of-life care within the community demonstrate the role PCPs play 
in these settings alone. Data were derived from a retrospective, linked administrative database 
study of people diagnosed with CRC between January 1, 2001 and December 31, 2005 in Nova 
Scotia, Canada. Adjusting for all covariates, filling a prescription for a strong opioid was associated 
with enrolment in a palliative care programme and is once again indicative of the role that palliative 
care services play in the provision of end-of-life care in the community. 
 
Practice variation in pain management has been a long-standing concern across health care settings 
and in a study conducted by Herr et al (56), hospices are no exception to that.   
Their findings highlighted the inconsistences associated with pain management across 16 
participating US hospices in the provision of pain management for older adults with palliative and 
end-of-life care needs.  Using baseline data from a large-scale, randomized, controlled, experimental 
study testing the effect of a multifaceted, translating-research-into-practice intervention to promote 
adoption of evidence-based practices (EBPs) for pain assessment and management in older adults 
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with cancer at end of life.  Findings suggest that EBPs for assessment and pain management for older 
cancer patients are not being fully implemented, or if they are, are not being documented.  As a 
result, research examining strategies to increase translation of EBP guideline recommendations to 
consistent use in hospice practice and research on the ability of this methodology to apply to a 
broader population and still retain its validity are needed.  
 
Studies focused exclusively on people over 65 related to palliative pain care management are scarce 
and the available evidence-based lacks high-quality RCT findings. The evidence that is available 
points to the importance of specialist knowledge provided by specialist palliative care teams and 
programmes designed to inform pain care management for older adults at the end-of-life.  Despite 
changes in demography, longevity and mortality whereby death and chronic illness are now largely 
concentrated in older age groups and, fundamental to achieving a ‘good death’, the paucity of 
articles meeting the inclusion criteria highlights the shortage of evidence on this important, yet 
hitherto neglected area of practice.  No evidence relating to the palliative and end-of-life care pain 
management of co-morbid or other long-term conditions such as COPD, heart failure or dementia in 
older adults were identified during the course of the review.  As such, further evidence is required to 
inform good clinical practice and the palliative care pain management for older adults with these 
conditions.  
Pharmacology  
Primary research in older adults 
As with the previous version of these guidelines (2), the results of the literature search demonstrate 
that very few studies focused on the use of analgesic medicines in older adults. A large proportion of 
the results were expert opinion, most of which were based on data extrapolated from studies 
involving adults between the ages of 18-65 years. 
Physiological changes in older people that should be considered when prescribing analgesia 
As adults age there are recognised physiological changes to various body systems which can affect 
the pharmacokinetics and pharmacodynamics of prescribed medicines. However, older adults are a 
heterogeneous population and often have multiple comorbidities so there are some general 
principles which should be considered when prescribing analgesia.  
General principles of pharmacological management of pain in older people  
The general pharmacological principles have not changed since the previous version of these 
guidelines (2) and are summarized below:  
 Always consider the use of non-pharmacological strategies such as physiotherapy, cognitive 
behavioural approaches and acupuncture, to reduce or eliminate the need for medicines. 
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• Physiological changes in older people increase the sensitivity to some analgesic drugs, which 
might necessitate appropriate dose titrations or replacement with an alternative medicine. 
• The incidence of side effects with drug therapy is higher in older people, particularly in the 
presence of comorbidities and polypharmacy. These factors need to be carefully considered when 
introducing new medication to minimise the chance of drug–disease and drug–drug interactions. 
• Always consider the route of administration. Although the oral route is preferred, as it is 
convenient and the least invasive, topical treatments may have similar efficacy to other routes with 
fewer adverse events. 
• Timing of medicine administration is important. Consider rapidly acting formulations with 
shorter half-lives for severe, episodic pain. This may need to be balanced with more regular 
background analgesia for patients who experience continuous pain. Ideally modified release 
formulations should be considered as this can improve adherence. 
• Only start or change one medicine at a time. Start with a low dose, use a slow dose titration 
and allow sufficiently long intervals to allow the assessment of effect. Treatment should be 
monitored regularly and, if required, adjusted to improve effectiveness and limit adverse events. 
• Combination therapy should be considered. Drugs with complementary mechanisms of 
action may have synergistic effects to provide greater pain relief with fewer side effects than higher 
doses of a single drug. 
Paracetamol 
Results 
Forty papers were identified which discussed the use of paracetamol in older adults. Of these, 34 
were classified as expert opinion, 4 were primary research and 3 were systematic reviews with 
meta-analysis.  
General advice 
Although there is considerable research into the effects of paracetamol on chronic pain, the majority 
of these excluded patients over 65 years (59). Paracetamol has long been viewed as an effective 
analgesic in a variety of inflammatory chronic pain conditions and has been considered as a safer 
alternative to non-steroidal inflammatory drugs (NSAIDs) (60). As a result it is often recommended 
as a first line treatment for chronic pain in older adults (40, 41, 61, 62).  
However, recent research suggests that paracetamol has very limited efficacy in chronic pain (64) 
and long-term use may be associated with significant risk of adverse events (65). These guidelines 




MD &PS Draft 09/05/2019   22 
Most expert reviews cite that paracetamol is an effective analgesic of chronic pain in older adults. 
However, recent systematic reviews with meta-analysis (although not specific to older adults) 
demonstrated very little benefit for short term use of paracetamol in osteoarthritis (64) and lower 
back pain (66). The only older-adult-specific study identified in this review was a small trial in 
patients with dementia, which showed that paracetamol (3g/day) was superior to placebo in terms 
of functional outcomes and patient involvement in activities (67).  
Adverse events 
A recent meta-analysis of 8 cohort studies demonstrated that there was an increased risk of 
cardiovascular and gastrointestinal adverse events and overall mortality associated with long term 
daily use of paracetamol (65). Previously, it was considered that no dose adjustments were 
necessary in older adults, unless there was evidence of hepatic insufficiency (68). There are now 
reports which suggest an increased risk of hospitalisation with older adults as a result of chronic use 
of paracetamol at doses higher than 3g per day (69, 70). In contrast, Fulton et al. (71) showed there 
was no increased risk of significant cardiovascular events in hypertensive older adults prescribed 
regular paracetamol. Although more research is needed in this area, the emerging evidence suggests 
that paracetamol should be used with caution in older adults. 
Non-steroidal anti-inflammatory drugs (NSAIDs) 
Results 
A total of 37 papers were identified which discussed NSAIDs. Most of these papers were not specific 
to older adults.  
General advice 
Since the publication of the first guidance (2), there has been little change in the use of oral NSAIDs 
in older people. In fact, if anything, awareness of their possible harmful effects has increased and 
strong caution has been expressed by different professional bodies (72). At present, no safe NSAID 
for oral use in older people is available in clinical practice. Furthermore, no effective medicine can be 
added to definitively protect against and prevent the possible adverse gastrointestinal (GI), 
cardiovascular and renal effects of this group of drugs. Although NSAIDs are effective analgesic and 
anti-inflammatory drugs, it is important to review regularly the balances between risks and benefits. 
Prescribing NSAIDs in older people needs to be patient-focused, specific and personalized to the 
individual patient and for a short course only. 
Adverse events 
A meta-analysis examining the cardiovascular safety of various NSAIDs found that naproxen was 
least harmful compared with other non-selective and selective NSAIDs (73). However, two recently 
published trials showed that the selective NSAID celecoxib, has a relatively superior upper GI 
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bleeding safety profile (CONCERN) (74) and a better cardiovascular risk profile (PRECISION) (75) 
when given with a proton-pump inhibitor (PPI). In the CONCERN study, patients included had a 
previous upper GI bleed and needed aspirin for cardio-prophylaxis, a clinical scenario commonly 
seen in older people. Although the two trials were not specific to older people, the mean age was 
approximately 72 years in the CONCERN study and 63 years in the PRECISION study. The CONCERN 
study concluded that celecoxib plus a PPI is the preferred choice of treatment in patients at high risk 
of both cardiovascular and gastrointestinal events and who require concomitant aspirin and NSAID 
(74). Alongside this recommendation, the trial showed that the risk of bleeding was unacceptably 
high at 6% and the cumulative risk (based on time-to-outcome analysis) for both celecoxib and 
naproxen was similar in the first 3 months. Given the high risk of adverse events, regular treatment 
with oral NSAIDs in older people should, in our view, be avoided unless absolutely necessary. In 
patients where a short course of oral NSAID is unavoidable, a lowest effective dose may attain a risk 
– benefit balance to justify treatment.  
Opioids 
Results 
There were 81 papers that included opioids. In studies of specific opioids, eleven different opioids 
were used (appendix, Table A). The most commonly studied drugs were opioids that were more 
recently marketed, including transdermal buprenorphine (14 studies), oxycodone (± naloxone) (10 
studies), and tapentadol (3 studies). The most commonly reported conditions were chronic pain (13 
studies), osteoarthritis (9 studies) and neuropathic pain (6 studies) (appendix, Table B). Thirteen 
studies considered the side effect safety of opioids, including risk of fracture (2 studies), side effects 
on initiation (1 study), and delirium (1 study). The quality of most publications was low (appendix, 
Table D). 
General advice 
Over time there has been greater caution in the use of opioids for the management of chronic pain 
(76). Limitations in trial design and duration have implications for the interpretation of outcomes, 
while concerns about side effects and harms are increasing. There is some evidence to support the 
short-term use of opioids in chronic pain but there are concerns over whether this efficacy is 
sustained with long term use (77).  
Specific opioids 
Codeine 
Often considered a ‘weak’ opioid, codeine may be appropriate where paracetamol and other non-
opioid analgesics have been ineffective in chronic non-cancer pain (62). In combination with 
paracetamol, codeine was equally effective as transdermal buprenorphine for the management of 
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painful osteoarthritis (78). Compared with other opioids, the risk of cardiovascular events was higher 
for codeine (RR, 1.62; 95% C, 1.27-2.06) after 180 days treatment and all-cause mortality was 
increased after 30 days (2.05; 1.22-3.45) compared with hydrocodone users (79).  
Buprenorphine 
Buprenorphine was the most commonly studied opioid. In the UK, the majority of prescriptions for 
transdermal buprenorphine were prescribed most frequently for painful osteoarthritis (80) and 
significantly more patients persisted with treatment at 6 and 12 months compared with those 
receiving other opioid analgesics, including tramadol, codeine and dihydrocodeine, despite 
increased incidence of constipation, dizziness, and nausea and vomiting. In a systematic review, 
there were no differences between transdermal buprenorphine and fentanyl in the incidence of 
dizziness, somnolence, nausea and treatment discontinuation (81). However, transdermal 
buprenorphine caused constipation for fewer people.  
Transdermal buprenorphine is less costly and more effective than transdermal fentanyl and 
oxycodone, showing better clinical outcomes at lower cost, and represents a cost-effective 
treatment option for patients with chronic pain from both health insurance and societal perspectives 
in Germany (82). In the UK, transdermal buprenorphine was estimated to be more cost-effective 
than tramadol with an incremental cost-effectiveness ratio of less than £7,000 (83). 
Fentanyl 
Fentanyl is an extremely potent opioid that is administered most commonly as a transdermal patch 
for the management of chronic pain. Compared with transdermal buprenorphine, fentanyl causes 
constipation for more people and leads to a higher number of serious adverse events (81). In 
Germany, transdermal fentanyl was less cost-effective that transdermal buprenorphine in patients 
with chronic pain over a time horizon of 6 years (82). 
Morphine 
In a retrospective chart review of ten carefully selected older patients with intolerance to other 
opioid analgesics seen at a tertiary care pain clinic in Toronto Ontario, morphine liquid was effective 
(pain intensity reduction 6.35 to 2.95) for serious biomedical painful conditions (84), mostly 
neuropathic pain and mechanical low back pain. The initial dose for all patients was 1-3 mg three 
times/day and maintenance dose ranged from 5 to 30 mg/day.  
Oxycodone 
Oxycodone has been available in Europe for approaching twenty years. It has good oral 
bioavailability and it produces more predictable plasma concentrations than morphine. When used 
to manage moderate to severe chronic osteoarthritis pain, oxycodone controlled-release (CR) has 
similar efficacy and tolerability with comparable side effect profile to other opioids (85). All-cause 
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mortality was elevated after 30 days for oxycodone users (RR, 2.43; 95% CI, 1.47-4.00) compared 
with hydrocodone users (79). When compared with no opioid, opioids including morphine, fentanyl, 
oxycodone, and codeine were not associated with delirium (86). 
Oxycodone/Naloxone 
The combination product of oxycodone/naloxone prolonged-release (PR) was developed to reduce 
opioid gastrointestinal side effects, particularly constipation. Naloxone binds preferentially to opioid 
receptors in the gastrointestinal tract and then undergoes extensive first pass metabolism in the 
liver allowing oxycodone to reach the central nervous system in order to exert its therapeutic effect. 
Several studies have evaluated the effects of oxycodone/naloxone PR for chronic pain in older 
people (87, 88, 89). Although studies have recruited a relatively small number of people, the results 
suggest that the combination is as effective as other opioid analgesics with improvements in bowel 
function and reductions in laxative use. In a pilot study, oxycodone/naloxone PR was effective in 
improving pain and other symptoms associated with dementia, with adequate safety and tolerability 
profiles (89). However, the combination product is included on the NHS England list of medicines not 
recommended to be routinely prescribed (90). But of course this only provides weak evidence 
according to Harbour & Miller (4) 
Tapentadol 
Tapentadol is a novel centrally acting analgesic with both opioid and monoaminergic activity. It does 
not have metabolites with significant analgesic activity, which theoretically presents some 
advantages, particularly in comparison with tramadol. In a systematic review comparing tapentadol 
extended release (ER) with oxycodone controlled-release (CR) in elderly adult patients (aged >75 
years) with moderate to severe, chronic osteoarthritis knee or low back pain, tapentadol ER was 
associated with significant reductions in pain intensity from baseline to week 15 compared with 
placebo (p = 0.0075); however, differences between the oxycodone CR and placebo groups failed to 
reach statistical significance (p = 0.1195) (91). With a dual mechanism of analgesic action, the overall 
opioid load is lower and this is associated with significantly less gastrointestinal side effects and 
constipation (92). Currently, there remains limited evidence to support the use of tapentadol over 
other opioids, which have been on the market longer, are less expensive, and have more established 
safety profiles (92). 
Tramadol 
According to consensus guidelines from the Canadian Pain Society, tramadol and controlled-release 
opioid analgesics are recommended as second-line treatments for moderate to severe neuropathic 
pain (94). Between 2007 and 2013, there was a marked reduction in tramadol prescribing in Swedish 
nursing homes (15) and a substantial rise in prescribing of other opioids.  
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A review on the management of persistent pain in older people proposed that if initial treatment 
goals are not met, a trial of a topical nonsteroidal anti-inflammatory drug or tramadol, or both is 
recommended (95).  
Compared with hydrocodone, after 30 days of opioid exposure the risk of fracture was significantly 
reduced for tramadol (RR, 0.21; 95% CI, 0.16-0.28) (78). However, in a cost utility analysis, tramadol 
was associated with 1,058 more fractures per 100,000 patients per year compared with transdermal 
buprenorphine (82). 
In a systematic review tramadol was associated with increased risk of delirium compared with no 
opioid (hazard ratio 7.1, 95% CI 2.2–22.5) (86).  
Opioid - Paracetamol combination therapies 
There been several studies evaluating the efficacy and safety of the paracetamol-tramadol 
combination product in treating moderate-to-severe pain. An observational, longitudinal, 
multicentre, open, non-comparative, prospective study in France demonstrated reductions in pain 
intensity, improved pain relief, patient satisfaction and clinical global impression evaluated by the 
patient, regardless of pain aetiology or duration of the underlying pathology (96). In an observational 
study in Japan of 24 older adults with chronic low back pain, a combination of paracetamol and 
tramadol (325mg/37.5mg) relieved leg pain greater and more quickly than back pain symptoms (97). 
However, over half of the patients reported significant gastrointestinal side effects (nausea, 
constipation or dizziness/vertigo), despite prophylactic treatment with anti-emetics. Whilst these 
studies are interesting, the combined paracetamol/tramadol preparation is also included on the NHS 
England list of medicines not recommended to be routinely prescribed (90). 
Adjuvant Drugs  
Results 
A total of 37 papers which discussed the role of adjuvant drugs (amitriptyline, nortriptyline, 
duloxetine, venlafaxine, carbamazepine, oxcarbazepine, gabapentin and pregabalin) for the 
treatment of chronic pain in older adults were identified. Most were expert reviews and not specific 
to older adults.  
Antidepressants 
Tricyclic antidepressants (amitriptyline and nortriptyline) 
Tricyclic antidepressants are thought to act mainly by modulating reuptake of noradrenaline and 
serotonin (and possibly through other mechanisms). They have been advocated as a first line 
treatment for neuropathic pain for many years. However recent systematic reviews conclude that 
there is limited evidence to support the efficacy of amitriptyline (98) or nortriptyline (99) in 
neuropathic pain due to the lack of good quality research. Despite this both amitriptyline (40) and 
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nortriptyline remain amongst the first line treatments for chronic neuropathic pain and fibromyalgia 
(100).  
The side effects of amitriptyline may limit its use in older adults, particularly with regard to 
somnolence, cardiovascular and gastrointestinal/bladder problems; and consequently, increased risk 
of falls. As such amitriptyline or nortriptyline should be introduced with caution and carefully 
monitored. 
Serotonin-noradrenaline reuptake inhibitors (duloxetine and venlafaxine) 
Duloxetine and venlafaxine both have similar mechanism of action. However, only duloxetine is 
recommended as a first line treatment for neuropathic pain (40). A recent systematic review 
demonstrated that duloxetine is effective in treating neuropathic pain but only at doses of 60 -120 
mg per day (101). These doses are unfortunately often associated with adverse events, although 
these tend to be mild. In contrast venlafaxine, despite having a similar mechanism of action to 
duloxetine, only has limited efficacy for neuropathic pain and is therefore not recommended (102).  
Duloxetine may also be beneficial in treating chronic musculoskeletal pain (103). A recent 
randomised, placebo-controlled trial demonstrated that duloxetine (60mg per day) improved pain 
and functional scores (50% duloxetine vs 9% placebo) in older patients with chronic osteoarthritic 
knee pain (104). Another study reported a secondary sub-group analysis of older patients (>65 years) 
from two previous clinical trials (105). These data showed that duloxetine (60mg/day) produced a 
significant reduction in osteoarthritis pain scores compared to placebo. However, 50% of patients on 
duloxetine reported adverse events (orthostatic hypotension, constipation, nausea and somnolence) 
which resulted in discontinuation by 22% of patients. A third, smaller study conducted a placebo 
run-in trial of duloxetine (90mg/day) in patients aged 50-80 years old (mean age 64 years) (106). 
Patients reported a significant reduction in pain intensity and physical function after 10 weeks of 
active treatment compared to a two-week blinded-placebo run-in period. Eight of 25 participants 
discontinued the study early.  
 
Of the remaining 17 participants, 14 experienced significant adverse events; the most common of 
which were sedation/fatigue, sexual dysfunction, constipation or diarrhoea. Although the efficacy of 
duloxetine in these studies is consistent with that of younger adults (103), the incidence of adverse 
events appears to be somewhat higher. 
Anticonvulsants 
Carbamazapine and Oxcarbazepine 
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Although carbamazepine and oxcarbazepine are not recommended as first line treatments for 
neuropathic pain, they are often used to treat the paroxysmal pain associated with neurological 
conditions such as trigeminal neuralgia (107).  
Recent systematic reviews showed that, whilst carbamazepine had some limited efficacy in 
trigeminal neuralgia, diabetic neuropathy and post stroke pain (108), there was little evidence to 
support the use of oxcarbazepine (109). Both studies reported a high incidence of adverse events of 
mild-moderate severity which precipitated a high withdrawal rate. The nature if these side effects 
(e.g. CNS depression, leukopenia, hepatic toxicity) suggest that carbamazepine should not be 
recommended for older adults (107). There may also be a high risk of very severe cutaneous adverse 
events in older adults treated for neuropathic pain (110). Moreover, as carbamazepine is a potent 
inducer of cytochrome p450 enzymes (notably CYP3A4, CYP2C9 and CYP1A2) it represents a 
challenge when patients are on multiple medicines (111). 
Gabapentin and pregabalin 
Gabapentin and pregabalin are advised as first choice drugs for older adult patients with neuropathic 
pain (40, 100). A recent systematic review showed moderate quality evidence for the efficacy of 
gabapentin in diabetic neuropathy and post herpetic neuralgia, but only at doses of 1800 – 3600 mg 
daily (108). Similar conclusions were drawn for pregabalin at doses of 300 – 600 mg daily (98). There 
was a relatively high incidence of mild-moderate adverse events with both gabapentin (63% 
patients) and pregabalin (≈50% patients); these included dizziness, somnolence, peripheral oedema, 
and gait disturbance. Neither of these studies specifically addressed older adults.  
A more recent study analysed the results from two randomised, placebo-controlled trials to compare 
the efficacy and tolerability of gabapentin (extended release formulation) in older (>75 years) versus 
younger (<75 years) patients with post-herpetic neuralgia (112). The results showed that at doses of 
1800mg daily, gabapentin significantly reduced pain scores in both age groups to a similar degree for 
up to 8 weeks. The incidence of adverse events were also similar in the two age groups (mainly 
dizziness, nausea and somnolence) which were most often reported at the start of treatment and 
were significantly reduced after the 4-week introductory period.  
 
A small cohort study (113) showed that pregabalin (75 mg daily) produced good-excellent pain relief 
in approximately 60% of older patients (mean age 72 years) with chronic lower back pain (with 
neuropathic pain). However, this was only monitored over a 4-week period and there was no 
placebo group.  
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A small, open-label study by the same authors (114) showed that pregabalin (150mg daily) produced 
a significant reduction in pain scores for patients with neuropathic pain associated with lower back 
pain after 4 weeks but was less effective against non-neuropathic pain. This contrasts with NICE 
recommendations for use of anticonvulsants for LBP without sciatica. 
Gabapentin and pregabalin are generally well tolerated and have few interactions with other 
medicines. However, each drug undergoes very little hepatic metabolism and so is reliant on renal 
excretion. Caution is therefore advised with patients with impaired renal function (115). Somnolence 
and sedation side effects are common in older adults and can exacerbate the effects of other CNS 
depressants (116). Some studies suggest that this can increase the risk of falls in elderly patients, 
particularly those living in a care home setting, but this has not been fully explored with ambulatory 
patients living in their own homes (117). A retrospective population-based study showed that there 
was an increased risk of hospitalisation as a result of altered mental status in older adults with high 
dose (>600mg daily) versus low dose (<600mg daily) gabapentin in the first 30 days following 
initiation of treatment (118). This risk was greater still in patients with impaired renal function. A 
lower starting dose and slower titration of gabapentin and pregabalin is therefore recommended. It 
should be noted that the new controlled drug classification of gabapentinoids to schedule C will 
necessarily influence prescribing habits. 
Topical Therapies 
Topical therapies may have an important contribution to make in pain management in the elderly. 
Specific benefits such as their efficacy, lower adverse events and the opportunity to be used as an 
adjunctive therapy, make them a valuable consideration.   
NSAIDs 
To avoid the systemic adverse events associated with oral NSAIDs, topical preparations have been 
recommended as an alternative. They are better tolerated and have fewer adverse effects (119). 
Depending on the carrier compound, the active drug penetrates the skin and enters soft tissue and 
joints at varying rate. Systemic absorption does occur but compared to oral NSAIDs, levels in the 
blood are much lower. However, a systematic literature review reported that gastrointestinal 
adverse events were experienced in up to 15% of older patients (95). Adverse local skin reactions 
(e.g. rash or pruritis) at the site of application have been reported in 10-39% of cases. 
A recent Cochrane review of available RCTs on the efficacy and safety of topical NSAIDs in chronic 
musculoskeletal pain in all ages (102) concluded that both topical diclofenac and ketoprofen 
provided good levels of pain relief in osteoarthritis but only for a minority of people. There was no 
evidence that it was effective in other chronic, painful conditions.  
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However, in a more recent meta-analysis of 43 studies, which included RCTs and observational 
studies, topical NSAIDs were superior to placebo in relieving local pain and improving function (120). 
It is felt that in osteoarthritis, topical NSAIDs are superior to other treatment options due to a 
combination of both contextual effects and specific treatment effects (121). These findings however 
were not specific to older people. 
Topical NSAIDs can therefore provide effective pain relief when localized to a few superficial joints, 
such as the hands or knees. Evidence from a recent randomized controlled trial showed comparable 
efficacy between topical diclofenac sodium and oral NSAIDs in knee osteoarthritis, and fewer 
adverse effects. Of all the topical NSAIDs, diclofenac patches were superior for osteoarthritis pain 
and piroxicam most effective for functional improvement. However, it is important to note that 
different preparations (e.g. gel, solution, patches) may have different effectiveness (120). Moreover, 
there is little evidence to support long term use of these topical preparations (99).  
Although no large, long-term studies in older people have been carried out, there is a consensus that 
topical NSAIDs are safe and effective in treatment of osteoarthritis. Many professional bodies have 
produced guidelines on the use of topical NSAIDs as first line choice of therapy in the treatment of 
osteoarthritis (122). 
Lidocaine 
Various clinical trials have suggested that topical lidocaine (5% medicated plaster) can be effective in 
the treatment of chronic neuropathic pain (123, 124). However, recent systematic reviews have 
demonstrated only low quality evidence to support the use of this treatment (99, 100) and it is also 
included on the NHS England list of medicines with limited effectiveness (90).  
Capsaicin 
A recent review of topical analgesics for acute and chronic pain in adults, they found that a single-
application of a topical high-concentration (8%) capsaicin patch had moderate quality evidence of 
limited efficacy in peripheral neuropathic pain (125). With respect to topical creams with low-
concentration capsaicin (typically 0.025%-0.075%) used for pain relief associated with post herpetic 
neuralgia, peripheral diabetic neuropathy and osteoarthritis, the authors found that evidence was of 
very low quality. Evidence on adverse event withdrawals were of very low quality. The authors also 
commented that there was no evidence in the reviews that specially related to older people. 
Summary Statements 
• Paracetamol can be considered for sort term treatment but should be used with caution for 
long term treatment for older patients with chronic pain. The efficacy of paracetamol in chronic pain 
is poor and there is emerging evidence that long term use can be associated with significant adverse 
events. 
 
MD &PS Draft 09/05/2019   31 
• NSAIDs should be avoided for the management of chronic pain in older people. A short 
course of NSAIDs can be considered on an individual basis, if the risk-benefit ratio is favourable, 
using the lowest effective dose for the shortest possible time  
• Although opioids may be beneficial in acute pain and at the end of life, there is limited 
evidence of benefit for many types of long-term pain, such as osteoarthritis and low back pain. 
Where used, doses should be kept low and intermittent rather than regularly. There are numerous 
opioids available and the choice will depend on pain intensity and co-morbidities. 
• Gabapentin, pregabalin, amitriptyline and duloxetine are recommended as first line 
treatments for neuropathic pain. Amitriptyline and duloxetine may also have some efficacy in 
treating other chronic pain conditions, such as fibromyalgia. Caution is advised in older adults due to 
central nervous system side effects and as such these drugs should be introduced gradually and 
carefully monitored. 
• Topical NSAIDs (ketoprofen and diclofenac) are recommended as first line treatment for 
short term pain relief in osteoarthritis as a safer alternative to oral NSAIDs in older adults. Capsaicin 
and lidocaine should only be considered as second line treatments for neuropathic pain. 
Psychological and psychosocial interventions to manage pain  
The previous guidelines noted that the evidence base for behavioural interventions was limited (2). 
Yet there is a considerable psychological component of pain which needs consideration. Pain is not 
only physically debilitating it has the potential to lead to social isolation, anxiety and depression. 
Hence, psychological methods utilise biopsychosocial approaches to focus on pain as a response to 
the interaction between nociceptive /neuropathic physical responses, emotions, thoughts and 
behaviours within a sociocultural context. A Cochrane review undertaken in 2011, (126) considered 
the potential for psychological interventions for pain management in heterogeneous adult 
populations and, noted that cognitive behavioural therapy (CBT) has a small effect in adult 
populations.  
Since 2009, the date of the search for the previous guidelines, interest in exploring the effectiveness 
of psychological approaches has expanded. Within the generic search in Medline ClNAHL and 
Proquest PsychINFO the following search terms were applied: 
psychological, psychology, psychiatric, mental health, depression, anxiety, suicide, self harm, well 
being / well-being, Cognitive Behavioural Therapy (CBT), cognitive behavioral therapy, compassion, 
pain management programme, Pain management program, pain self management. 
Some 956 papers were identified as potentially suitable using the above criteria (MD & ZM) out of 
which 53 papers were selected for closer scrutiny.  
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Using the SIGN criteria (Scottish Intercollegiate Guidelines Network 2015), two reviewers (PS & MD) 
agreed and graded the following 14 research papers (see table) in this review. The retrieved papers 




Cognitive Behavioural Therapy  
Andersson et al (127) in a study of the older people with chronic pain randomly allocated 21 people 
either to a CBT intervention arm (n=11) or a waiting list. The older people were recruited from a 
newspaper advertisement for people with chronic neck or back pain. Only minimal effects were 
noted in the intervention group. In a 2014 study, older people (N=367) with osteoarthritis and 
insomnia were subject to six weekly sessions of CBT (128). This was a randomised cluster trial with 
three arms CBT for pain (n=122), CBT for pain and insomnia (n=122) and an educational only group 
(n=123). Post treatment and nine months later, outcomes measured included pain severity, 
insomnia severity and depression. Attempts were used to accommodate missing data and linear 
regression modelling used to estimate all effects at 18 months. What is noteworthy from this study 
is that the effect sizes for those who received the sleep and pain CBT intervention suggest greater, if 
only small, potential long-term benefits. 
A form of CBT was considered in a 2016 trial (129) with people experiencing hip and knee pain 
(N=256). The effects of the intervention were noted in this multisite RCT, one group received 
training in Pain Coping Skills (PCST) whilst the other received the usual care package. Though some 
small benefits were noted, when utilising pain scales, outcomes in terms of distress and pain 
catastrophizing showed little improvement. Those of greater age were noted as being more 
responsive to the intervention. However, reported distress and coping with distress, as experienced 
by some of the participants, appeared to be confounding factors for interventions involving self-
management.  
The benefits of CBT as part of a pain management programme were considered in an Australian 
study of older people (N=141) with a history of chronic (non-cancer) pain (26 ). Participants were 
randomised to one of three arms Exercise Attention (n=53), Pain Self-Management (n= 49) and a 
waiting list group (n=39). Measures including pain intensity, pain distress and pain catastrophizing 
were considered post intervention, at one month, six month and twelve month intervals.  
Regression analyses were applied to consider some of the relationships between outcome measures 
and it was noted that pain (post intervention) was predictive of pain at one year and pain 
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catastrophizing was related to the experience of pain and disability over time. However, some 
overall benefits of CBT over exercise were noted in this population. 
Pain Management Programmes 
Green and colleagues (30) devised a psychosocial pain management programme for older adult and 
tested it on 95 older people living in the community. Out of the total 46 received the 10-session 
intervention and 49 did not. Data was collected post intervention and then 3 months later, pain 
beliefs and some coping behaviours appeared to improve but overall pain outcomes were not 
enhanced by the intervention.  
In a later study, an intervention involving a three week outpatient 'pain rehabilitation programme, 
including opioid withdrawal, was applied to three adult age groups, those aged 18--39, the 40-59 age 
group and those aged over 60 (130). The intervention was assessed using the multidimensional pain 
inventory (MPI), health, depression and pain catastrophizing scales. The older participants (>60 = 78) 
reported a greater improvement in all outcomes at 6 months following the programme. The 
consumption of medication, including opioids, was also significantly reduced. On the whole the older 
age group in this study did better on a range of assessments including pain severity, depression and 
perceived control. 
Ehrenbrushoff et al (131) considered the evidence for psychological interventions for back pain in 
older people, finding only three trials (N=271) which were suitable for inclusion. However, there was 
little evidence that the combination of psychological interventions, mindfulness, CBT and 
meditation, with physical exercise had any effect when compared with placebo. In a more recent 
review of psychological approaches Eccleston et al (132) found only three trials which considered 
older people with small improvements noted following pain management programmes. 
Heterogeneity of populations, small sample sizes and other methodological issues appeared to 
confound the findings in each of these reviews. Of note, both reviews identified research largely 
originating from the same research institute (University of Pittsburgh School of Medicine). 
A University of California randomised controlled trial compared acceptance and commitment 
therapy (ACT) and cognitive and behavioural therapy (CBT) for chronic pain in older and younger 
adult populations (133). The older participants (n=21) older people were particularly responsive to 
ACT. The 8-week ACT arm focused on helping the older people to live well with pain rather than 
reduce it, the benefits were reflected in the responses in the Brief Pain Inventory interference scale. 
 
Residents from 10 nursing homes in Hong Kong who had experienced pain in the last 6 months were 
randomised to either an integrated pain management programme IPMP (n=296) or a control group 
(n=239) (134). The IPMP group received an 8-week programme of exercise and either multisensory 
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stimulation therapy or art and craft activity with significant reduction in measures of pain intensity 
(p < 0.001). However, it cannot be established whether the activity or the exercise component was 
the beneficial element. In a subsequent study the same team used motivational interviewing and 
physical exercise programme as an intervention with 56 older people with chronic pain in nursing 
homes (134). The 31 participants in the 8-week intervention arm showed significant improvements 
(p < 005) in pain intensity, pain self-efficacy, anxiety, happiness and mobility. 
 
 
Other psychological interventions 
A team at the university of Pittsburgh undertook a feasibility study using an 8-week mindfulness 
programme with older adults (>65) (135). The educational intervention, a Mindfulness-Based Stress 
Reduction Programme was randomised to 140 in the intervention arm and 142 in the control arm. 
Unfortunately, short term improvements were not maintained and were statistically insignificant. 
Another educational intervention utilised by Barefoot and team (136) contrasted the 10-week 
intervention (n= 23) of a Pain Self-Management Programme incorporating a self-help book with a 
control group (n= 14). Those in the self-management group found the information helpful but this 
was not reflected in improved pain using a variety of measures. 
Guided imagery, and its potential benefits for older people in pain, was explored in a study of 31 
older people in a Thai residential care home (137). Depression, stress, anxiety and pain scales were 
used in a pre-test post-test study to consider the benefits to two groups; one receiving usual care 
the other the intervention. After a 16-day intervention period the two groups were compared and 
no benefits were noted to either group. With such small numbers this study was not generalisable; 
however the absence of any effects even in a heterogeneous small sample such as this is 
questionable. 
The effect of humour as a pain-relieving intervention was considered in an RCT of older people in 
Iranian nursing homes with some benefit noted. Humour was utilised in the form of 6 x 60 minute 
sessions over a period of 6 weeks. The intervention group (n= 28) and control group's experiences 
were contrasted with the pain intensity in the intervention group significantly lower (138).  
It would appear that there is still limited evidence for CBT as an effective treatment for chronic pain 
in older people however; the numbers of papers which consider pain management programmes and 
more novel interventions suggest that combined or integrated strategies to manage chronic pain 
may be beneficial to older populations. It is important to note that amongst these studies there is no 
standard agreement of the content of what CBT or any of the Pain Management Programmes should 
consist of. 
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Physical activity as pain management  
Promotion of physical activity is an important component of management of persistent pain in 
adults, and a recent overview of systematic reviews concluded from the available evidence that 
physical activity and exercise may help with pain, physical function, psychological function and 
quality of life, while being associated with few adverse events (139). The quality of the evidence was 
considered to be low, mainly hampered by the small size of studies, and the findings were not 
conclusive (139).   
This overview was not exclusive to older people with persistent pain yet the findings are consistent 
with current thinking about this population, expressed in our previous guidance (2)  
This is that increase and maintenance of physical activity in older people with persistent pain is 
important to counter the deleterious consequences of inactivity on fitness, function, independence 
and quality of life commonly found in this population (2). 
 
Our updated search of literature found more studies focused on people over 65 with persistent pain. 
However, such studies are still relatively few and high quality evidence in the form of RCTs with low 
bias remains scarce. The evidence from the studies (140, 141, 142, 143, 144, 145) adds varying 
degrees of support to our previous interpretation of the evidence that pain and function can be 
improved with interventions comprising strengthening, flexibility and endurance activities to 
increase physical activity (2). The previous guidance highlighted the potential of incorporating 
balance exercises into programmes because of the link between persistent pain and falls in older 
people (2). That link has since been further demonstrated and balance training was incorporated 
into new studies (140, 144). 
 
Still live is the question as to which type of exercise should be selected for which type of individual 
older person with persistent pain. The current crop of papers provide no further insight into this 
question, which goes beyond the scope of what they set out to do. Still live, therefore, is our 
previous recommendation, based on conclusions from a review of low back pain for adults of all ages 
(2) that the selection of activity and exercise should be heavily influenced by the preference of the 
older person with persistent pain. Such preference will, of course be tempered by the availability 
and accessibility of required facilities. The new papers (again because it is out of scope of their aims) 
add little to the previous recommendations that the level of activity should be tailored to the 
individual’s capacity, and the recommendations from American guidelines pertaining to this remain 
apt (146).  
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The new papers add to the range of activities that have been applied and evaluated for older people 
with persistent pain – dance (147), Qigong (148); and modified yoga (149). This points to an 
increasing set of options to those previously listed - walking, progressive resistance exercise, aerobic 
exercise, water-based activity, and activities sometimes classed as body-mind exercise like yoga and 
Tai-Chi. Exergaming, the use of virtual reality and gaming technology for exercise, continues to 
develop and has been applied for older people with persistent pain. An alluring aspect of exergaming 
lies in the possibilities of using virtual environments when required real facilities are unavailable or 
inaccessible.  
 
The previous guidance accentuated the importance of motivation and overcoming barriers to 
activity and exercise (2).  
The basic premise is that activity or exercise will not be of benefit if the person does not actually 
carry it out, however powerfully its benefits are suggested or prescribed. The previous 
recommendations were that cognitive-behavioural approaches and supervision should be used to 
facilitate the benefits of activity for older people with persistent pain. Three studies combined 
cognitive behavioural therapy (26), counselling (140) and motivational interviewing (143) to their 
exercise programmes but the effects of these were not tested in isolation from the exercise. Neither 
of the studies showed any evidence to suggest that such approaches should not be used. 
 
Some of the studies discuss the use of exercise/activity in the context of self-management and the 
value of exercise/activity for self-management by “aging” adults (as opposed to exclusively adults 
over 65) with persistent pain has been reported (150). One new study reported the findings of an 
intervention combining the Chronic Disease self-management Programme with exercise reporting 
short-term improvement in physical function and possible benefits for pain in older adults with 
persistent pain (151).  
 
In conclusion, the recommendations from the previous guidelines still apply. While there have been 
more studies carried out exclusively in older people with persistent pain these are still few in 
number and of variable quality. 
Recommendations/summary statements 
• Exercise/physical activity may benefit pain, physical function, psychological function and 
quality of life 
• Exercise should involve strengthening, flexibility, endurance and balance, customised to 
individual capacity and needs.  
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• Motivation and barriers to exercise/physical activity should be discussed and planned for. 
• Personal preference should be considered as an important motivating factor in negotiation 
of exercise/physical activity.  
• Exercise/physical activity can form an important part of self-management.  
Education  
A major barrier to persistent pain management is a lack of understanding by the person with pain as 
to what their pain is and how it affects them. People are more inclined to rationalise their 
experience of persistent pain in the context of acute pain using a biomedical model of disease and 
cure that is a poor fit compared to a biopsychosocial model. Education is used as a potential solution 
to manage pain.   
 
A systematic review of randomised controlled trials of educational intervention for adults with 
persistent pain concluded that the evidence base for effects of education was of limited quantity 
and quality; and that there was insufficient evidence of benefits of education on its own on pain or 
disability (139). This was consistent with the only study included in the review that used a sample of 
adults over 65 years: this small sized trial reported increased knowledge of pain following education 
but no effects on pain, while disability was not measured (152). Our current search found no further 
high quality evidence.  
 
The systematic review of Geneen (139) did suggest that a particular form of education - Pain 
Neurophysiological Education (PNE) - showed some evidence of a decrease in disability, increase in 
psychological coping and increase in knowledge about persistent pain. A subsequent meta-analysis 
of studies investigating PNE showed no significant effects on pain; statistically significant reduction 
of disability that did not reach criteria of clinical significance; and statistically and clinically significant 
improvements in psychological coping (153). Neither that review nor our current search found any 
high quality evidence about PNE specific to adults over 65 with persistent pain. One study, in a 
subgroup analysis of a sample of adults over 50 with persistent low back pain produced low quality 
evidence to raise a possibility of PNE increasing understanding about pain for adults between 70 and 
79 (32). 
 
While awaiting specific evidence about adults over 65 with persistent pain, it is sensible, in theory 
and taking a lead from evidence in adults over 18, to recommend that education is offered alongside 
other pain management approaches.  
Interventions 
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This section represents an update of the 2013 guidelines. It does not replace the previous guidelines 
and as such these guidelines still stand today. These guidelines examine the same disorders as 
previously addressed however, there remains limited studies relating to pain in older people. 
Trigeminal neuralgia (TN) 
No new relevant studies since 2013. 
Spinal stenosis 
Spinal stenosis is the narrowing of the spinal cord leading to compression of the nerve roots causing 
back and leg pain. It is commonly associated with lower limb paraesthesias and leg weakness.  It is a 
common condition affecting older adults.  
 
Karm et al (154) reported the results of a randomised, single blinded, active-controlled trial in which 
60 patients with refractory central lumbar spinal stenosis with neurogenic claudication were divided 
into groups who underwent percutaneous epidural adhesiolysis (PEA) using inflatable balloon 
catheter or not. Patients were assigned to receive either the balloon-less catheter (n=30; 66.1±2.2 
years) or the inflatable balloon catheter intervention (n=30; mean age 65.51±6.4 years). The 
procedural techniques of the interventions were described in detail. The outcomes were measured 
at baseline, 1, 3 and 6 months after PEA. The results showed significant difference between groups 
in the Numerical Rating Scale (NRS-11), the Oswestry Disability Index (ODI) and Global Perceived 
effect of Satisfaction (GPES) and Medication Quantification Scale III. At 6 months there was a 
significant difference between the groups, pointing to better outcomes among patients who had PEA 
using the inflatable balloon catheter. The use of inflatable balloon catheter in PEA led to significant 
pain reduction and functional improvement. It can be concluded that PEA with inflatable balloon 
catheter is a better intervention option in patients with lumbar spinal stenosis than balloon-less 
catheter PEA.  
In a study of 62 patients with lumbar spinal stenosis, Briggs et al (155) examined the effectiveness of 
epidural steroid injections. In a single centre, prospective non-randomized, observation study, 
patients who had not had any previous lumbar injections within 6 months or lumbar surgery were 
selected. The mean age of patients was 74 years. Following skin preparation and local anaesthesia, a 
20-gauge, 3-5-inch Tuohy spinal needle was advanced using a fluoroscopic guidance towards the 
intended interlaminar target site. A 5mL injectate consisting of 1mL Triamcinolone acetonide 
[40mg/mL] and 4mL0.5%preservative-free Xylocaine was administered.  For the caudal injections the 
preparation administered was a 10 mL of injectate made up of 1mL triamcinolone acetonide 
[40mg/mL], 5 mL preservative-free normal saline and 4mL preservative-free 0.5% Xylocaine. The 
outcome measures were the SF-16 Questionnaire which assesses functional health and wellbeing. 
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Covariates that could affect responses to pain treatment were also assessed and included gender, 
age, body mass index, history of hip or knee replacement surgery and comorbidities. The results 
showed improvement in pain scores at 1 month and 3 months post injection form the baseline. A 
higher emotional health score at baseline, indicated association with greater pain reduction over 3 
months. Similarly, patients who were assessed as obese at baseline showed significant improvement 
in pain scores over 3 months compared to non-obese patients. The study demonstrated that lower 
back pain in this group of patients (LSS) can be relieved with injection treatment but varies in 
association with personal characteristics, patients with healthier emotional status and obesity  
reporting more pain relief over 3 months post injection. It was not clear from the findings presented 
and discussed whether or not there was any difference in pain alleviation noted between the caudal 
and the laminar routes of administration.  
Manchikanti et al (156) reported the results of a 2-year follow-up randomized, double-blind, 
controlled trial of fluoroscopic caudal epidural injections in central spinal stenosis (LCS). The study 
design was to test the effectiveness of caudal epidural injections with or without steroids in 
providing long-lasting pain relief in patients with chronic low back pain associated with lumbar 
central stenosis (LCS). Patients (n=100) were randomly assigned to one of two groups. Group I 
patients (n=50; mean age 56.9±14.5 years) received caudal epidural injections of local anaesthesia, 
lidocaine 0.5% preservation-free. Group II patients (n=50; mean age 55.7±15.9 years) were 
administered epidural injections of 10ml made up of  0.5% lidocaine, 9mls mixed with 1 ml of non-
particulate betamethasone, 6mg. This was followed by an injection of 2mls of 0.9% sodium chloride 
solution to flush the content from the sacral canal. The outcome measures were in part similar to 
those used by Karm et al (154) and included the Numeric Rating Scale (NRS), the Oswestry Disability 
Index2.0 (ODI), employment status, and opioid intake. Baseline scores were compared with 
treatment and control groups at 3, 6, 12, 18 and 24 months intervals. The results showed that 
patients receiving the intervention reported higher percentage of improvement but without 
statistically significant difference between the two groups. This led to the conclusion that caudal 
epidural injections of local anaesthetic with or without steroids effect pain relief in a modest 
proportion of patients with LCS.   
Kamihara and colleagues (157) reported a study into the efficacy of spinal cord stimulation (SCS) for 
the treatment of leg pain associated with lumbar spinal stenosis (LSS). The leg pain experienced and 
reported by patients with LSS was considered as mixed pain. It was hypothesised that such pain 
would respond to SCS treatment. Data form 91 patients, mean age 73.2 years, were collected 
retrospectively. The procedures used before and during the use of SCS were described, included a 
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trial stimulation before the SCS was used. The technical procedure and the instruments used were 
described.  
The results included analysis of subgroups. 59 out of the 91 patients had shown 50% or greater 
alleviation of pain. In all 41 patients underwent the implantation of a pulse generator in the left 
hypogastric region. 39 out of 41 patients showed a good response to SCS, sustained for one year or 
longer. The results showed no significant intergroup difference on efficacy.  
The authors concluded that SCS was effective in the management of leg pain associated with LSS and 
deemed useful in pain relief during the time between conservative and surgical therapy.  
In another selected study of the use of spinal cord treatment (SCS) in the treatment of of chronic 
pain in patients with LSS, Constantini et al (157) evaluated the long-term patient outcomes.  
 
 
Data from three European centres were analysed. 69 patients aged between 46-94 years with a 
mean age of 70±10.1 years, with intractable chronic pain associated with LSS underwent a similar 
procedure as described by Kamihara et al (158), in 34 patients a single lead was applied whereas in 
35 patients two leads were applied. Pain was measured using a visual analogue scale (VAS), quality 
of life measured with the Oswestry Disability Index (available for only two centres, N=28) and 
baseline data was compared with a median follow-up of two years. Results showed that the VAS 
score improved significantly from baseline readings, with a mean improvement of 63% at 24 months 
follow-up. Patients also reported decreased use of medication which included opioids and NSAIDS. 
Patients also reported improved quality of life. It was noted that six patients experienced adverse 
events in the form of lead dislocation and system infection. 
The literature evaluated in this section seem to offer diverse treatment modalities in the 
management of pain associated with spinal stenosis. Depending on the location of the stenosis, the 
findings of studies suggest that epidural steroid injections or percutaneous epidural adhelyosis (PEA) 
can be techniques of choice in specific type of stenosis with equal effectiveness in alleviating pain.  
Similarly, the results of studies on effectiveness of spinal cord stimulation suggest that in selective 
cases patients should benefit from pain relief for a considerable length of time if not completely 
cured. Recommendations for the choice of treatment will be based on thorough medical 
examination and the results of investigations.  
Vertebroplasty & Kyphoplasty  
A fresh search of the literature on Medline did not yield any papers that met the inclusion criteria. 
Most papers were related to fractures. 
Postherpetic Neuralgia pain 
 
MD &PS Draft 09/05/2019   41 
Postherpetic Neuralgia pain (PHN) is a common cause of pain in older adults and is a complication of 
herpes zoster due to neural ischaemia and can become irreversible.  
Ma and colleagues (159) reported a study they conducted with 40 patients with the administration 
of high-frequency repetitive transcranial magnetic stimulation (rTMS). The mean age of patients was 
65.4 years. They termed it a ‘sham stimulation controlled randomized trial’ with three phases: 1) a 
baseline optimal medical treatment for 15 days; 2) rTMSsessions for 10 days; and 3) 1-month and 3-
month follow-up evaluations. Patient who completed phase 1 were included in phase 2.   
The application of magnetic stimulation was undertaken using a magnetic stimulator with a liquid-
nitrogen-cooled coil oriented to the scalp. The intervention consisted of 10 sessions, each session 
comprising of 300 five-second pulses with a frequency of 10 Hz, administered at an interval of 3 
seconds between each administration, giving a total of 1500 pulses per session.    
The main treatment outcome was pain relief as recorded before stimulation to final stimulation 
(session 10), and at 1 and 3 months, after final simulation (session 11 and 12). Other outcome 
measures included pain intensity, using the McGill Pain Questionnaire (sf-MPQ), Visual Analogue 
Scale (VAS), sleep quality (SQ), depression (Self Rating Depression Scale, SDS), impression of change 
(Patient Global Impression of Change, PGIC) and medication regulation (MR).  
The results showed that there were no adverse events related to the rTMS in either the 
experimental or control group. The results showed VAS was significantly reduced in the intervention 
groups than the control group. There were no significant changes reported in the VAS reduction rate 
associated with age or duration of pain.   
The findings suggest that repeated daily stimulation deliver prolonged pain relief lasting 1-3 months 
than a single rTMS session with effects lasting less than a week. Recommendations 
The treatment of postherpetic neuralgia pain in older people is limited to findings of this one study. 
However, it is clear that repetitive transcranial magnetic stimulation (rTMS) can be of value in 
selected patients with postherpetic neuralgia in relieving pain for up to 3months.  
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Appendix Two: Types of painful condition studied 
Condition Number of studies 
Osteoarthritis   9 
Renal colic    1 
Chronic pain 13 
Neuropathic pain   5 
Pain in dementia   1 
Low back pain    1 
Pain in frail older people   1 
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Appendix Three: Search Strategies & Terms Used 
Main Search as applied in Medline with results on 30.05.18 
2009-March2018 inclusive 
Limited to English language 
S1.  
AB ("older adults" OR elder OR elderly OR seniors OR senior OR geriatrics OR aging OR ageing OR 
"age related" OR "over 65*" OR pensioner) OR TI ("older adults" OR elder OR elderly OR seniors OR 
senior OR geriatrics OR aging OR ageing OR " age related" OR "over 65*" OR pensioner)    
S2. 
AB (pain OR "pain management" OR "pain relief" OR "pain control" OR "pain reduction") OR TI (pain 
OR "pain management" OR "pain relief" OR "pain control" OR "pain reduction")   
      
 
S1 + S2 combined         
  
EBSCOhost generic search in Medline AND ClNAHL combined (N= 6751): 
 
Link to search in Proquest PsychINFO (N=1,173) 
 
Appendix Four: Search strategy for attitudes section 
In addition to the standard terms used, key search terms used included ‘attitudes’ and ‘beliefs’. A 
total of 140 papers were identified from database searches and a further 5 from additional searches 
(reference lists and Google). Following a review of the titles, 117 were excluded and 23 referred for 
abstract review. Of this 23, 4 papers were excluded and 19 full texts were reviewed. A total of 12 
papers were included from the database search. Additional searches returned 5 papers, of which 4 
were excluded. A final 13 papers are included in the review (Figure X). 
Figure X: Flow Chart for Attitudes & Beliefs Search  
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Papers were primarily excluded as they either focused on the attitudes, beliefs or education of 
healthcare providers; reported on populations below 65 years; or did not provide a breakdown of 
results by age where age-range was spread. The following inclusion and exclusion criteria was 
applied:  
Exclusion Criteria:  
• Did not include over 65 years plus.  
• Referred to attitudes, beliefs or education of healthcare providers. 
 Not published in English. 
Inclusion Criteria: 
• Studies referring to attitudes and beliefs in relation their impact on:  pain intensity, 
psychological impact, functional impairment, and coping strategies. 
• Intervention studies designed to change attitudes and beliefs.  






 Abstract Review 19 Extracted  Abstract Review 4 Excluded  
Full Text Review 12 Extracted Full Text Review 7 Excluded
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• Reviews including studies from post 2009 only. 
 
Methodologically, most papers included are cross-sectional studies which implemented 
questionnaires (6), 3 papers used qualitative methods, and 4 papers reported on educational 
programmes. Given the subject matter, it is unsurprising cross-sectional methods are the most 
popular form of study design. The absence of RCTs and prominence of cross-sectional methods is 
reflected in the level of evidence grading which predominantly cluster around grading 2 (Harbour & 
Miller). Papers were derived from 6 countries, the USA was most popular (6), followed by the UK (2). 
Other countries included Brazil (1), Australia (1), Spain (1) and Hong Kong (1).  
Appendix Four: Guidelines Search Summary 
In addition to the standard terms used, key search terms used included ‘guidelines’ and 
‘recommendations’. A total of 258 papers were identified from the database searches. Following a 
review of the titles, 234 were excluded and 24 referred for abstract review. Of this 23, 22 papers 
were excluded and 2 full texts were reviewed. A total of 22 papers were included from the database 
search. Given that guidelines were not likely to have been published, rather circulated through pain 
society websites, additional searches were carried out. These additional searches of pain societies 
and reference lists from database articles returned an additional 14 papers for review. From these 
11 papers 3 were extracted for inclusion. A total of 5 papers were therefore included.  
Flow Chart of Search for Guidelines  
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Papers were primarily excluded as they were opinion or discussion based, providing an overview of 
expert recommendations or a review of challenges/evidence in the area. Other papers were 
excluded as they discussed existing guideline content or were not official guideline documents. From 
additional searches a number of official guideline documents were identified, however only those 
included actually referred to older adults, or gave significant reference to them. Many guidelines 
made brief reference or made general recommendations which were not aged discriminative.  
The following inclusion and exclusion criteria were applied:  
Exclusion Criteria:  
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• Did not include any or significant reference to older adults (>65 years).  
• Not official evidence-based guidelines, based on expert opinion or discussion piece.  
 Not published in English. 
 Not accessible or open-access.  
Inclusion Criteria: 
• Evidence-based guidelines referring to pain management in older adults.  
• English.  
• Published after 2009. 
 
Methodological appraisal was not appropriate for papers included, given that included guidelines 
have appraised included evidence.  
Appendix Five: Carers search 
Databases (Medline, CINAHL, PsycINFO, Cochrane and AMED) were searched using the following 
search terms: 
 
Search terms were the same as Margaret’s original S1 + S2 and then combined with (AND) S3. 
S3 
AB (caregiv* or carer or “informal carer” or “unpaid carer”) OR TI (caregiv* or carer or “informal 
carer” or “unpaid carer”) 
March 2009- March 2018   
English Language   
 
 
149 papers were initially identified, resulting in a yield of 98 after removing duplications. Titles and 
abstracts were reviewed independently by two reviewers (GB and SAF) according to the inclusion 
and exclusion criteria below.  
Inclusion criteria 
• Unpaid (informal) carers of any age contributing to the care of an older adult aged 65 years 
and above living with chronic pain 
• Chronic pain is defined by self-report 
• Naturalistic enquiry with no restrictions on setting of study 
• Empirical studies providing data directly from carers 
• Peer-reviewed published papers 
Exclusion criteria 
 
MD &PS Draft 09/05/2019   70 
• Professional/paid carers 
• Carers contributing to the care of those under the age of 65 years 
• Unpublished theses and conference papers 
• Published papers based on expert opinion and/or commentary 
Any discrepancies were discussed and a final sample of 10 papers that focused on chronic pain in 
older adults and the roles of, and impact on, carers were included in the final analysis.  Overall, the 
levels of evidence of the ten articles included in this section of the review were graded as low. 
Appendix Seven: Palliative Search 
A total of 155 articles were identified by searching the relevant databases. These included AMED, 
Medline, CINAHL, PsycINFO and Cochrane using the search terms Pain, Pain Management, Older 
People and the MESH alternatives (older people >65) and any of the following terms Hospice, 
Palliative, Terminal, Dying, End of Life and Dementia. Many of those initially identified did not relate 




MD &PS Draft 09/05/2019   71 










Age Group Type of 
Pain 
Results  Grade 
 Camacho-
Soto, A.  
2012 USA Cross 
Sectional  
Questionnaire Community  200  
 
Mean age= 
73.9 years  
Low back 
pain 
Fear avoidance beliefs 
were significantly 
associated to poorer 
physical performance 
and increased disability.  
2  
 Cornally, N. 2011 UK Cross 
Sectional 
Questionnaire  Community  72 60-74 years 
(57%) 










effected by education, 
gender, pain intensity 
and level of stoicism.  
2 
















associated to more 
adaptive pain beliefs 
and use of relaxation 
coping strategies.  
2+ 
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 Holden, M. 2012 USA Cross 
Sectional 
Questionnaire 
Interviews   
Community  1,276 
59%  
Mean age= 
66 ± 10 years 
 
57% female, 
43% male  
Knee pain  There are many barriers 
and facilitators to older 
adults’ willingness to 
engage in exercise. 
However, less than 50% 
agreed exercise was 
beneficial to knee pain.  
2 







Knee pain Integrated exercise-
based rehabilitation 
programme for arthritic 
knee pain was not 
associated with 
improved beliefs about 
knee pain, however 
were more willing to 
engage in exercise to 
manage knee pain.   
2 






29% female  
Knee pain  The management of 
knee pain is the 
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Beliefs relating to 
exercise and ageing 
were improved 








Community 93 Mean age= 





Back pain  Older adults do not seek 
help for back pain due 






 Makis, U. 2014 USA Cross 
Sectional  
Interview Community 23 Mean age= 





Back pain   Older adults perceive 
restricting back pain 





 Miro, J.  2014 Spain Cross 
Sectional           





Older adults who have 
maladaptive pain beliefs 
have greater activity 
2 
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 interference and poorer 
psychological wellbeing.  
  Nicholas, 
M. 
2017 Australia  Intervention Questionnaire  Community 141 Mean age= 
74 years  
Chronic 
pain  




distress, depression and 
fear avoidance beliefs 
for older adults with 





 Teixeira, L. 
F. 
2016 Brazil Cross 
Sectional 








Attitudes and beliefs of 
LBP is related to 
depression, disability 
and poor expectation of 
return to activities. 
2 









Pain related attitudes is 
positively associated to 
depression, poorer 
physical and mental 
health status, pain 
intensity and loneliness. 
2 
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Appendix Nine: Informal caregivers and pain management  
Reference 
no  





Type of pain Intervention/Study 
type 
Results Grade 








medical wards of 
an acute general 
hospital- 65 













symptoms was better 
for informal care givers 
(ICG) than health care 
professionals (HCP). 
The ICG is a better 
proxy than the HCP 
and results highlight 
best proxy pain 
agreement by the ICG.     
2+ 






Case study  Findings from three 
case studies indicate 
3 
 







that a behavioural in-
home intervention 
designed to teach 
caregiver(s) how to 
recognise signs of pain 
and distress in people 
with dementia (PWD) 
may help prevent the 
development of 
aggression and pain in 
PWD. 


















Perceptions of the 
relationship of pain to 
behavioural and 
psychiatric symptoms 
of dementia (BPSD) as 
reported by informal 
caregivers as proxy 
indicate that pain is a 
more significant 
predictor of behaviour 
for individuals with 
2- 
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severe dementia 
compared to those 
with mild/moderate 
dementia. 
 Hsu, K-Y.  2015 Taiwan Convenience 






from a medical 
centre and 








Qualitative descriptive Older adults commonly 
shared their pain with 
their adult children 
and reflects the 
importance of family 
as a support system in 
Chinese society. Family 
caregivers observed 
their older relatives’ 
had limited pain 
management 
strategies but provided 
few pain management 
strategies to help.  
Most participants had 
limited knowledge of 
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associated with the 
use of pain medicine 
was evident.     
 Kaiser, R. M.  2016 USA 90 year old 
woman in 
receipt of care at 
a hospital and 
her two children.  
90 Abdominal 
pain 
Case study Paper recounts how 
poor communication 
between and among 
clinical teams is 
pervasive.  The patient 
and family were not 
consistently listened 
to, or integrated, into 
the clinical team.       
3 










Not specified Randomised controlled 
trial  
A focused intervention 
designed specifically 
for caregivers of PWD 
at risk of increased 
aggressive behaviour 
due to pain, no 
significant differences 
in aggression incidence 
between intervention 
and control groups 
1- 
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were found.    
 McPherson, 
C. J.   
2013 Canada  Purposive 
sample of 18 
patients with 
advanced cancer 
in receipt of 
palliative care at 






 Cancer pain Qualitative descriptive Cancer pain explored 
from the perspectives 
of older patients and 
their caregivers living 
at home identified 
three main themes: 1. 
Feeling cancer pain 
2. Reacting to cancer 
pain 
3. Living with cancer 
pain 
The findings emphasise 
the need to assess 
cancer pain within the 
individual’s current 
circumstances in the 
context of life-limiting 
illness, caregiving and 
ageing. 
3 
 McPherson,  2014 Canada  Purposive 
sample of 18 
Mean 
age 




MD &PS Draft 09/05/2019   81 
patients with 
advanced cancer 
in receipt of 
palliative care at 







1. Communicating the 
pain including: their 
roles in pain 
assessment, 
identification and 
expression of pain, and 
the communication of 
pain between patients 
and caregivers. 
2. Finding a solution 
including: roles and 
approaches in 
controlling pain, beliefs 
about cancer pain 
control, experience 
with side effects and 
perspectives on goals 
and treatments.   
An emphasis on dyads 
rather than separate 
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experiences of patients 
and caregivers gives 
credence to the 
interactional process 
of caregiving.    
 
 Murray, T. 
M.  
2012 USA Convenience 
sample of 115 
PWD and 150 
caregivers 
recruited as 
dyads from an 
outpatient 
geriatrics clinic.  






in the paper 
Retrospective  Pain was the leading 
symptom reported by 
PWD and caregivers.   
3 
 Pillemer, K.   2017 USA 285 older 
mothers and 678 
adult children 








Self- report.  
Not specified. 
Survey No effects on 
emotional closeness or 
tension in relationships 
between adult children 
and older mothers 
who experienced 
higher levels of 
persistent pain.   
2- 
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Appendix Ten: Palliative Care 
Reference 
no  





Type of pain Intervention/Study type Results Grade 







cancer pain Standard care (602) 
compared with palliative 
and supportive care 
ePSC (848) 
ePSC integrated with 
primary oncologic care 
(relative risk 0.69; 95% 
confidence interval 
0.48-0.99; P=0.045) 
was an independent 
factor associated with a 
31% reduced risk of 
suffering from severe 
pain. An ePSC team 
provides the most 
effective standard of 
analgesic therapy for 
cancer pain. 
2 
 Fisher 2014 Canada 657 people 
with colorectal 
cancer in Nova 
Scotia 
>66 cancer pain retrospective data 
analysis 
36.7% filled at least 
one prescription for 
any opioid in the six 
months before death. 
3 
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Persons were less likely 
to fill a prescription for 
a strong opioid if they 
were older (OR=0.97, 
95% CI=0.95-0.99), 
male (OR=0.59, 95% 
0.40-0.86), and 
diagnosed less than six 




Programme (PCP) may 
play an important role 
in enabling access to 
end-of-life care within 
the community. 
 Herr 2010 USA 16 US hospices 
N=399 
>65 cancer pain Experimental 
interventional study 
pain intensity following 
evidence based practice 
pain interventions 
83.5% of patients with 
admission reports of 
pain had an order for 
pain medication. 
review of the pain 
2+ 
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(EBPs) and guidelines treatment plan at each 
reassessment (35.7%); 
reassessment of 
moderate or greater 
pain (5.3%); 
consecutive pain 
reports of 5 or greater 
followed by increases 
in pain medication 
(15.8%); monitoring of 
analgesic-induced side 
effects (19.3%); 
initiation of a bowel 
regimen for patients 
with an opioid order 
(32.3%); and 
documentation of both 
nonpharmacological 
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highlight positive EBPs 
and areas for 
improving the 
translation of EBPs into 
practice.  
 Laguna 2012 USA 484 seriously ill 







>65 Mixed, acute 
& chronic 
Longitudinal cohort 
study, 2 year Pre-test 
post test 
Mean pain was 
significantly different 
between baseline and 
later measurement 
Findings support IPC 
teams’ effectiveness in 
managing pain during 
hospitalization but 
suggest a lack of 









>65 Mixed, acute 
& chronic 
retrospective 
Effects of inpatient 
palliative care on self-
reported pain, and 
Individuals were asked 
to rate their pain 
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in pain after the 
intervention. Despite 
pain decreases, Latinos 
remain more likely 
than whites to report 
pain at follow-up. 
 
Appendix Eleven: Pharmacology  





























Significant reduction in 















Significant pain relief 
(100-250 mg twice daily) 














Incidence of recurrent GI 
bleeds over 18 months: 
2++ 
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 Opioids 15 studies 
5540 patients 
Pain intensity 
 Chronic low 
back pain 
Low-medium quality 
evidence for short term 
efficacy for opioids versus 
placebo. There is no 
support for long term use 























reduction in pain scores. 
High drop-out rate and 
high incidence of adverse 
















evidence for efficacy of 
pregabalin (300-600mg 




















Topical diclofenac and 
ketoprofen can provide 
good pain relief for 
1++ 
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drugs (NSAIDs; 
topical)  
minority of people. 
Some evidence that 
substantial placebo effect 
from carrier gel. 
(Derry et 
al., 2017) 





















Limited efficacy of topical 
diclofenac and 
ketoprofen in chronic 
hand and knee 
osteoarthritis. 
Limited efficacy of 

















Low quality evidence for 


















Neuropathic No evidence to support 
use of topical lidocaine to 












Various 229 studies 
 




































Initialisation of treatment 
with higher doses of 
gabapentin (>600mg per 
day) resulted in higher 
risk of hospitalisation 
versus lower doses (<600 































Small but significant 
increase in persistence 
with buprenorphine 
patch treatment over 6-
















 78% of patients 
experienced pain 
reduction >30% after 52 
2+ 
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pain (NRS) weeks 
(Gupta and 
Li, 2013) 
Gupta 2013 USA Placebo 
controlled 
RCT 














Significant reduction in 
pain scores for >75 years 
or <75 years versus 
placebo.  
1+ 













  Buprenorphine was 
superior to fentanyl and 
oxycodone in terms of 
QALY and lower cost 
3 
(Hemmings









 Opioids 4933 patients 
(2814 in 2007 













 Increase in overall use of 
opioids between 2007 
(62.8%) and 2013 (66.5%) 
2+ 
(Imamura, Imamura 2015 Japan Open label  Tramadol 24 patients Mean Chronic low A significant reduction in 3 
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back pain leg pain was observed 
after 1 week. Lower back 
pain was reduced after 1 
month 
(Kim et al., 
2013) 







Neuropathic Carbamazepine is 
associated with a 10-fold 
increased risk of severe 

















Various 60% of patients reported 
a pain improvement of ≥ 
30% after 60 days with a 






Lee 2015 USA Retrospecti
ve chart 
review 












After 14 months, patients 
reported a mean 3.4 






Lunn 2014 UK Systematic 
review 




Duloxetine at 60-120mg 
per day is effective in the 
1+ 
 




Fibromyalgia treatment of chronic 
neuropathic pain 
(moderate quality) and 





















Paracetamol is ineffective 
at reducing pain intensity 
or improving quality of 





Makris 2014 USA Case report 
and review 
 Various 92 studies 
3 patients 
  Conservative approach to 
pain management in 
older adults 













2663 patients >65 
years 
 64.8% of patients 
reported a reduction in 
pain intensity (-3.1 




Micca 2013 USA Post hoc, 
subgroup 
analysis of 








A significant reduction in 
pain intensity over 13 
weeks vs placebo in both 
1- 
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younger and older 
groups.  
A significantly greater 
discontinuation due to 













Low quality evidence for 
limited efficacy in 























The risk of cardiovascular 
AEs was the same for 
celecoxib, naproxen or 
ibuprofen.  
The risk of GI AEs was 
lower for Celecoxib 


















Lack of evidence does not 
allow any 
recommendations for 
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(Petrò et 
al., 2016) 
Petrò 2016 Italy Prospective









 A significant reduction in 
pain intensity (6.6±1.0 vs 














Various Significantly increased 
risk of cardiovascular and 
gastrointestinal adverse 
events, and mortality 




















Pregabalin produced a 
small but significant 
reduction in pain 
intensity after 4 weeks. 
Tramadol/paracetamol 
produced a small but 
significant reduction in 




Sakai 2015 Japan Open label 
prospective 
trial 








23/32 patients reported 
good or excellent pain 








 Paracetamol 3 trials 
1825 patients 
 Low back 
pain 
No significant difference 
was noted between 
1- 
 
MD &PS Draft 09/05/2019   97 
2016) Pain intensity 
QoL 




Solomon 2010 USA Matched 
cohort 
 Opioids 6275 patients Mean 
age 78 
Various Significant variation in the 





Sullivan 2009 USA Single blind, 
placebo 
run-in trial 






improvement in patient 
reported pain scores and 











Opioids 6 studies   Tramadol and meperidine 
had increased risk of 
delirium compared with 










 NSAIDs 31 studies 
116,429 
patients 
  All NSAIDs reviewed had 






Wiffen 2017 UK Systematic 
review 







evidence that gabapentin 
is effective in some 
people with neuropathic 
1+ 
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pain at doses of >1800 
mg per day 
(Wiffen et 
al., 2014) 
Wiffen 2014 UK Systematic 
review 








Limited efficacy in 
neuropathic pain with 
relatively high incidence 
of adverse events. 
Adverse event 













56 studies   Buprenorphine patches 
were better tolerated 
than fentanyl and may 
offer reduced incidence 
of adverse events for 
















Topical NSAIDs are 





Zhou 2017 China Systematic 
review 





Little evidence to support 
the use of oxcarbazepine 
in neuropathic pain 
1+ 
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y 
 
Key : ADP: average daily pain, API: average pain intensity, BPI: brief pain inventory,PHQ-9: Patient Health Questionnaire-9, SIS: sleep interference score, 
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Appendix Twelve: Psychology  
       SIGN 
grade 
Andersson 2011 Group based CBT RCT 11 Exp 
10 Control 72 
years + 
Canada Supports CBT. But numbers 
very small 
3 
Barefoot  2012 Pain Management workbook RCT  54 Exp  
46 Control 
65 years + 
Can Satisfied with PSM manual 
but recommends more 
research 
3 






N = 28 Exp 
N = 27 Control 
Iran Significantly lower pain in 
experimental group 
3 
Broderick 2016 Pain Coping Skills Training RCT N=256 USA small improvement in pain 
noted, greater in oldest 
participants 
3 
Darchuck  2010 complex intervention including 







USA reports of significant 
improvements at 6 months 
post treatment 
1 
Elsegood 2012 Guided imagery pre-test, post-
test study 
N=31 Thailand No significant effect noted 1 
Green  2009 Pain Management programme 





Canada Some changes in pain 
beliefs and behaviour 
3 
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N=49 wait noted in oldest participants 




N=367 USA CBT no significant benefits 
noted 
1+ 





USA only short term benefits of 
intervention  
3 
Nicholas 2017 Training in pain self-
management 




N= 39 waiting 
Australia significant effects of CBT at 
1 year 
3 
Tse 2012 Integrated pain management 
programme 
cluster RCT N=535 
N= 296 
intervention 
N= 239 control 
 
HK, China post intervention 
significant reduction in pain 
intensity noted 
3 
Tse 2013 motivational interviewing and 
physical exercise 
RCT blinded N=56 
N=31 
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intervention 
N=25 control 
Weatherell 2016 compared acceptance and 
commitment therapy (ACT) and 







USA Older adults more 
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Appendix Thirteen: Physical Activity  
 
First author  Year Study design  Intervention  Sample Age  Main results Grade 
Foley 2011 RCT The two experimental 
interventions were gym-
based exercise programmes 
(including resistance, 
Aerobic, flexibility and 
balance training) varying 
only in frequency of 
delivery: either once or 
twice a week, directly 




centre for older 











Most of the outcomes 
(69%, 11/16) were 
maintained over the 
intervention period with 
no 
Significant group effects 
detected.  
Physical activity levels 
recorded in the control 
group showed a  
significant proportion of 
participants were actively 
exercising once weekly 
1+ 




the effect on adherence, 
motivation, 
enjoyment and balance 
abilities of conventional self-
regulated exercises with 






who are referred 





adherence, measured as 
1+ 
 





hospitals or by 
general 
practitioners. 












2016 RCT !  Group (A) received treadmill 
aerobic exercise, while the 
second group (B) was 
considered as a control 
group and received no 





disease with age 
ranging from 65 
to 75 years  
Intervention 
group 68.94 
(5.76) CG  
69.13 (6.12) 
Treadmill walking exercise 
training is an effective 
treatment policy to 
improve quality of life, 
systemic inflammation and 
psychological wellbeing in 
Alzheimer’s. 
1+ or ++ 
 



























All participants performed a 
program which consisted of 
stretch and strength 
exercises with traditional 






















After the 10 weeks 
exercise, RF, VL, and VM 
activities of all participants 
had significant increased 
and pain the knee had 



















Two-group pre-post test 12 
week (24 sessions) Healthy-
Steps intervention group 
n=19vwith a wait-list control 
group n=15. The wait-list 
control group did not 
participate in the dance 
sessions during the study 












therapy is a feasible option 
with preliminary efficacy 
for increasing gait speed 
for older adults with 
lower extremity 
pain/stiffness. Also, results 
showed no statistically 
significant reduction 
in pain/stiffness between 
1+ 
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 the two groups. However, 
compared to 
baseline, there was a 
suggestion of pain/stiffness 
reduction within 
the dance group (P ¼ 
0.094) 
LAU 2014 Pilot study 
with before 
and after 
design – non 
comparative  
individual and group 
exercises were delivered 
twice a week 
for 10 weeks in a public 
indoor swimming pool by 
registered physiotherapists 
Elders aged 65 
years and above 
attending any 
one 





In this study, the 
intervention was 
associated with a reduction 
in knee pain, improved 
strength of knee extensors, 
improved knee ROM, and 
overall body balance; all of 
which were confirmed by 




Tse 1 2014 RCT  PEP was an eight-week 
training program given by 
physiotherapist and nurses 
once a week. It consisted of 
warm-up exercises, muscle 
396 Older 




IG with PEP 
(n ¼ 225, 
age ¼ 85.45 
(6.2), CG 
without the 
eight-week  PEP, including 
muscle strengthening and 
stretching for the painful 
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strengthening, stretching, 
balancing, and self-
administered massage to 
acupressure points. The 
control group received no 
training during the eight 
weeks 
musculoskeletal 
pain six months 
prior to the 
study 
 
PEP (n ¼ 
171, age ¼ 
85.44 
(6.35). 
was effective in reducing 
pain and improving 
psychological function and 
joint mobility. In addition, 
the participants who 
attended the PEP had 
significantly lesser pain 
than those who had not 










2011  RC clinical 
trial  
The intervention lasted for 
12 weeks, 3 times per week. 
The participants were 
randomized into two groups: 
(1) squat training with 
whole-body vibration, and 







VG 75 (5), 
EG 71 (4) 
Comparison between the 
functional performance of 
participants in the 
postintervention period 
and at baseline shows an 
improvement in the group 
of individuals allocated 
to WBV associated with 





Brovold 2012 RCT For the the IG The exercise 
program consisted of 
108 participants 
recruited from 
79 (6.5) 79 
(6.9) 80 (6.1 
The results from this study 
show that the additional 
1++ 
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counselling, balance- and 
progressive resistance 
training and support from 
the physical therapist at 
Geriatric Day- 
Hospital (GDH) and after 
discharge at home. (2 
phases). The Control-group 
received counselling, 
balance training 
and support from the 
physical therapies 
GDH in Norway 
were 
randomized into 
the (IG) (n = 53) 
or (CT) (n =55). 
resistance exercises for the 
IT-group resulted in less 
pain and more energy 
after 12 weeks of training 
but that participants in 
both groups 
(balance only and 
combined resistance and 
balance) reported 
increased their physical 
functioning 
HUI 2009  RCT  Intervention group (IG), 
which included 23 sessions 
of dance (ow impact aerobic 
dance) over 12 weeks, or a 
control group (CG) were 
they continue their usual 
daily activities. All 
participants were assessed 







seniors in the 
Shatin District 
of Hong Kong 
IG 68.0 (4.5) 
CG 69.1(4.2) 
For the ‘body pain’ domain 
in SF-36, the mean score of 
IG 
decreased from 78.67 to 
76.92 (score difference -
1.75) from 
baseline to 12 weeks, 
whereas the mean score in 
the CG increased 
from 74.62 to 81.00 (score 
1++ 
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difference + 6.38). 




The intervention group for 
Sit and Fit yoga consisted of 
two 45-minute sessions per 
week for 8 weeks. CG 
received a Health Education 
Programme (HEP) program 
consisted of two 45-minute 
sessions per week for 8 
weeks. Participants in this 
group received general 
health education about OA.  
38 Participants 
were recruited 




with AD who 
randomised to 






There was no significant 
difference between groups 
in initial pain level (HEP = 
13.06, yoga = 13.85, P = 
.819). The fixed effects 
indicated no significantly 
greater decrease in 
perceived pain over time 
for the chair yoga group 
when compared with the 

















The intervention is allocated 
to 2 groups MSET and MSCT, 
which consisted of 6 
sessions about 1.h hours 
each. Each session was 
divided into 2 parts: 1) a 
multi-sensory stimulation 
session 2) 30 min teaching 
exercise for the MSET and 
82 participants 




into 2 groups 43 
for MSET and 39 
for the MSCT. 
Mean Age 
72 (9.5),  
71 (8.4) 
Both groups reported 
significant improvement in 
PA, anxiety scale, 
happiness scale, and 
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 2016 Phase 
I/phase II 











specifically adjusted  GA 
treatment regimen to the 
needs of older adults with 
chronic low back pain, these 
adjustments were then 
paired with educational 
messages and a few 





older adults  
with chronic low 











There was a clinically 
relevant increase in 
physical 
function by 20.3%, and a 
decrease in pain intensity 
2++ 
Oh  !! Cross- 
sectional 
Survey !! 











The intervention group 
involved attending a 2-h 
weekly exercise session for a 
total of 12 classes. Each 











For the 144 participants 
with knee pain who 
completed the trial, there 











health check-up and 90 min 
of lecture plus exercise. The 
control participants were 





(n = 98) take part 
in the exercise 
class; CG (n = 
222) who did not 
wish to join the 
exercise class, 
but agreed to 
cooperate in the 
survey. 
 
either VAS or WOMAC pain 
score at baseline between 
the intervention and 
control groups. In men, 




Irandoust  2015 Design not 
mentioned!! 
 





The aquatic program was 
conducted in a heated pool 
(depth 1.20m) at water 
temperatures between28 
and 3°C consisted of 2 
aerobic sessions and 1 
session of resistance 
training. All sessions lasted 
60 min and included a 
warm-up period (10 min), 
the main program (40 min), 
and a cool down period (10 
32 elderly men 
from Qazvin, Iran 
Aquatic 
training, 
with a mean 
age of 
68.4±2.9 yr 
(3 d/wk for 






Low back pain significantly 
decreased in the aquatic 
training group (p<0.05) 
1+ or ++ ! 
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min). The aerobic regimen 
included exercises such as 
water walking, jogging, 
walking and jogging in 
combination with various 
arm movements, 
sidestepping, water cycling, 
and adapted water games 
(volley and basket). The 
subjects in the control group 
did not participate in any 
kind of exercise program. 
They were asked to carry out 
their usual daily activities. 
Kim H. 2013    RCT Women with knee pain 
(n = 150) were randomly 
assigned into four groups; 
exercise (Ex) and heat/steam 
generating sheet (HSGS) 
(n = 38), Ex (n = 37), HSGS 
(n = 38), or health education 
(HE) (n = 37. Ex group 
302 who 
reported knee 





>75 The results showed VAS 
improvements in the Ex + 
HSGS and HSGS groups. 
Total JKOM score, muscle 
strength, and functional 
mobility significantly 
improved in the Ex + HSGS 
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attended a 60-min 
comprehensive training 
program twice a week for 3-
months 
HE group. The combined 
effects of both Ex and heat 
therapy seems to have an 
added benefit of 
decreasing pain 
Kim M. 2016 Single blind 
RCT 
Self-exercise with a 
therapeutic inflatable ball 
(SEIB) and US therapy (twice 





the study. All 
participants had 
MTrPs in the 
upper trapezius 
on at least one 
side for 3 
months or longer 
SEIB (n = 22; 
mean age, 




therapy (n = 
18; mean 
age, 67.99 – 
5.64 years) 
The noninferiority test 
indicated that SEIB was not 
inferior to US for VAS, PPT, 
and CLF. SEIB for 4 weeks 
has an effect similar to that 
of US for desensitizing 
myofascial pain and 
increasing joint flexibility 








2018 RCT The SMEG (the treatment 
group) performed a 90-
minute intervention twice a 
week for 12 weeks. The first 













The main findings of this 
study demonstrated that 
the participants in the 
SMEG had significantly 
better results after the 
intervention than the 
individuals in the EG in the 
1+ 
 














and the following 60 
minutes were allotted for 
the exercise component. The 
EG (the control group) 
received a book,12 
telephone calls, and three 
education sessions. Both 
groups (SMEG and EG) also 
received a supplement of 
glucosamine (1500 mg) and 
chondroitin (1200 mg) 
sulfates, harpagophytum 
extract (100 mg), and 
hyaluronic acid (10 mg) with 
a recommendation for the 
use of two sachets per day 
Educational 





CWP scale (a component of 
the self-management 
behavior variable) and 
health-related physical 
fitness measures (aerobic 
capacity and functional 
lower limb strength) 
Peungsuwan  2014 RCT  The TPT and SPT programs 
consisted of two phases. The 
first phase include class-
based TPT and SPT group 
intervention programs at an 
appointed public indoor 
31 patients with 
KOA aged 50–85 







TTP group  
67.8±6.4 
After 2 months, the six-
minute walk test (6MWT), 
Western Ontario and 
McMaster Universities 
Arthritis Index (WOMAC), 
and SF-36 testing showed 
1++ 
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area. The second phase was 
performing the actual home 
self-care program with TPT 
or SPT alone, at least three 
times/week for twelve 
months. Each exercise was 
performed five 
times/session, two sets/day, 
and this was increased every 
two weeks until reaching 40 
times/session 






significant improvement in 
both groups, but the 
improvement of the TPT 
group was greater. After 
1year, only the score for 
the 6MWT was greater in 
the TPT group than in the 
SPT group. [Conclusion] 
The TPT program yielded 
better results for the 
6MWT, but, both programs 
had beneficial effects on 
the pain, function, and 
QOL of middle-aged and 
older patients with KOA in 









8-week MIE was developed 
for community-dwelling 
older persons with chronic 
pain.  A weekly session 
provided for 15 hours in the 




sampling in two 
elderly 
community 
>65  Significant improvements 
in pain intensity, pain self-
efficacy, anxiety, happiness 
and mobility after the 
motivational interviewing 
and physical exercise 
1++ 
 










programme consisted of two 
main components: MI 
counselling, also regarded as 
pain education, and physical 
exercise, regarded as a pain 
controlling and coping skill. 
At the same time, the 
control 
group followed their regular 
activities in the centres 
during the eight weeks 
 
 
centres in Hong 





programme (p<0.05) for 
experimental group, while 
no significant improvement 
in control group except on 










2009 RCT Patients were randomly 
assigned to 1 of the 2 
treatment groups (qigong or 
exercise therapy) or the 
waiting list group in a 1:1:1 
ratio. Both qigong and the 
exercise therapy consisted 
of 24 sessions (each 45 
minutes), were held over a 
117 patients 
were recruited at 
4 residences for 
elderly people, 




mobile and lived 
Mean age 
for : 
Q 75.9  (7.6)  
 
E 76.0  (7.2 ) 
 
W 75.7 (7.6) 
The study found no 
significant effect after 3 
months of qigong or 
exercise therapy compared 
with no treatment. Also, no 
significant differences for 
pain, neck pain, disability, 
and quality of life among 
the 3 groups. 
1++ 
 
















period of 3 months (2 
sessions per week) in groups 
of 6 to 12 participants and 
used the same gymnasiums. 
Patients in the waiting list 
group did not receive qigong 
or exercise therapy for the 
whole period. After 6 
months they were offered 
an intervention of their 
choice. 
independently in 
their own flats. 

















There were 302  participants 
in the intervention group 
who received the CDSMP 
immediately, and 365 
participants in the wait-list 
control group who received 
 IG  
72.57 (8.57)  
CG 
76.05 (7.94) 
Of the 10 outcome 
measures in health status, 
5 showed more favourable 



















usual care for 6 months limitation (p=0.004), 
depressive symptoms 
(p=0.001), health distress 
(p=0.014), and 















       2012  RCT Randomly allocated groups 
to one of 3 conditions: Pain 
Self-Management (PSM), 
Exercise-Attention Control 
(EAC), and Waiting List (WL) 
control 
141 patients 
with chronic pain 
conditions 
referred by their 
doctor for 








>65 Immediately post 
treatment indicated that 
relative to the Exercise-
Attention Control (EAC) 
group, the PSM group was 
significantly improved on 
measures of pain distress, 
disability, mood, unhelpful 
pain beliefs, and functional 
reach. Relative to the WL 
group, the EAC group 
made no significant gains 
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Two  hundred  eighty-five 
received care from a PT 
randomized to the 
intervention 
group, and 303 received 








Service of New 
York (VNSNY), 













73.0 (9.9) The treatment and UC 
groups had significant 
reductions in 
pain-related disability, pain 
intensity, and ADL 
limitations 
and increases in gait speed. 
No significant treatment 
differences were 
identified. Subgroup 
analyses failed to identify a 
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Appendix Fourteen: Interventions section* 










Results CASP  
Score 











aged 60 and 







62 patients, 61 
still enrolled at 3 







Changes in pain 
scores at 1 month 









(SD22.0) at one 
month and 35.8 
(SD=19.0) at 
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emotional health 
and body mass 
index.  































opioids from 29% 
to 13%, NSAIDs 
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analysed form 
193 patients in 
each group. 
plus Lidocaine 
group and the 
lidocaine alone 
group.  


















400 patients  
with back or 





372 patients were 
treated at 
baseline and 
were included in 









plus lidocaine had 
reduces cortisol 






an increase in 
cortisol.  
1+ 
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stenosis 
(LSS) 
rate, 65% years Mixed pain Good response to 
SCS continued for 
one year or more 
after 
implantation in 
39 patients (95%) 






























allocated to each 
groups (balloon-
less group, n=30) 
and (inflatable 
balloon group, 
n=30), lost at 
follow-up, with 
intention to treat 
analysis at 6 
months on 20 and 















the groups on 
measures of pain, 
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(n=24) or the 
s-rTMS 
group (n=25) 
There were losses 
in each group 
during allocation 
and follow-up,  
leading to 
eventual analysis 
of data from 20 















Pain intensity was 
measured. 
The real rTMS 
group greater 
reduction in pain 
intensity at each 
point of 
measurement 
except for the 
first and second 
point. Results 
showed rTMS to 
be an effective 
and safe therapy 
for this group of 
patients.  
1+ 













100 patients.  
 
All patients 































(LCS) lidocaine only 
whilst 57% in 
intervention 
group, at the end 
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Appendix Fifteen: Guidelines  
Ref No First Author Year  Country  Summary   
 Miaskowski, 
C. 
2011 USA A supplementary document to The American Geriatrics Society (AGS, 2009) 
guidelines on the management of persistent pain. Based on the expertise of 
3 members of the AGS who developed the 2009 update.  
 Schofield, P.  2013 UK Summary of previous 2013 guidelines (Abdulla et al., 2013). Concludes that 
many interventions and pharmacological treatments require further 
research in older adult populations. The evidence-base for non-






2009 USA Update of 2002 AGS guidelines. Concludes that evidence-base at the time 
of publication was not adequate or sufficiently exhaustive to inform 
routinely encountered clinical decisions in relation to managing pain in 
older adults. 




2013 UK Guidelines for the development of pain management programmes for older 




2018 Australia Guidelines for the assessment and management of pain in older adults 
living in long-term care settings. Updated from 2003 guidelines with the 
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Pain Society  addition of sections on nutrition and end-of-life.  
